{"gene":"TBX5","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":1997,"finding":"TBX5 is a T-box transcription factor whose mutations (including nonsense and missense mutations) cause Holt-Oram syndrome, establishing TBX5 as critical for limb and heart development; haploinsufficiency of TBX5 is sufficient to cause the syndrome.","method":"Genetic cloning, mutation identification in affected pedigrees, positional mapping to chromosome 12q24.1","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational disease gene identification replicated across multiple pedigrees and subsequently confirmed by many independent labs","pmids":["8988165"],"is_preprint":false},{"year":2001,"finding":"TBX5 physically interacts with NKX2-5 (cardiac homeobox protein); the interaction requires the N-terminal domain and N-terminal T-box of TBX5 and the homeodomain of NKX2-5. TBX5 and NKX2-5 together synergistically activate the NPPA (ANF) promoter. The HOS-causing cardiac missense mutation G80R abolishes this synergy, while the limb-predominant R237Q mutation does not.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation in COS-7 cells, co-transfection/luciferase reporter assays, overexpression in P19CL6 cells with functional differentiation readout","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (yeast two-hybrid, GST pull-down, co-IP, reporter assays, cell differentiation), replicated by independent labs","pmids":["11431700"],"is_preprint":false},{"year":2003,"finding":"GATA4 physically interacts with TBX5; a HOS-associated GATA4 G296S missense mutation abrogates this interaction. Specific HOS-causing TBX5 missense mutations similarly disrupt the GATA4-TBX5 physical interaction, indicating cooperative transcriptional activation through this complex.","method":"Co-immunoprecipitation, GST pull-down, luciferase transcriptional assays, genetic linkage and sequencing","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP and pull-down, replicated with multiple disease-causing mutations, independently confirmed by subsequent studies","pmids":["12845333"],"is_preprint":false},{"year":1999,"finding":"TBX5 is expressed in a graded fashion in the developing heart: strong posteriorly and in the left ventricle but absent from the right ventricle and outflow tract. This chamber-specific expression pattern correlates with the cardiac defects observed in HOS (atrial septal defects, left-sided malformations).","method":"In situ hybridization in developing mouse and chick hearts; correlation with human HOS cardiac phenotype","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization with functional consequence (chamber-specific phenotype prediction), replicated across species and confirmed by subsequent functional studies","pmids":["10373308"],"is_preprint":false},{"year":1999,"finding":"HOS missense mutations at residue 80 (Gly80Arg) primarily cause cardiac malformations whereas mutations at residue 237 (Arg237Gln/Trp) primarily cause skeletal malformations; structural mapping to the Xbra T-box showed residue 80 contacts the major groove of target DNA while residue 237 contacts the minor groove, suggesting organ-specific TBX5 activity depends on biophysical interactions with different target DNA sequences.","method":"Clinical phenotype analysis of 10 HOS mutations correlated with structural modeling of TBX5 T-box based on Xbra crystal structure","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — phenotype-mutation correlation supported by structural inference; mechanistic model replicated by later biochemical studies","pmids":["10077612"],"is_preprint":false},{"year":2001,"finding":"TBX5 binds a specific 8 bp core DNA sequence (part of the Brachyury consensus binding site) including the full palindromic and half-palindrome Brachyury sites; amino acids 1-237 are required for DNA binding. HOS mutations G80R and R237Q eliminate binding to target DNA. TBX5 activates an ANF reporter construct in a T-box binding-site-dependent manner.","method":"In vitro binding site selection assay, EMSA, cell transfection/luciferase reporter, mutational analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding assay with mutagenesis and functional transcriptional readout; single lab but multiple orthogonal methods","pmids":["11555635"],"is_preprint":false},{"year":2002,"finding":"Zebrafish tbx5 (heartstrings mutation, premature stop at aa316) is required for pectoral fin bud formation and for cardiac looping morphogenesis; homozygous mutants lack pectoral fins entirely and show progressive cardiac deterioration. Tbx5 functions very early in pectoral fin induction and coordinates fin outgrowth axes.","method":"Forward genetic screen, positional cloning, morpholino knockdown, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function allele combined with morpholino experiments; defined cellular phenotypes; ortholog confirmed","pmids":["12223419"],"is_preprint":false},{"year":2002,"finding":"Tbx5 is required for formation of the pectoral fin bud in zebrafish; morpholino knockdown results in complete loss of pectoral fins through a defect in directed migration of lateral plate mesodermal cells into the limb-bud-producing region.","method":"Antisense morpholino knockdown, histological analysis of mesodermal cell migration in zebrafish","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Moderate — morpholino loss-of-function with cellular phenotype (mesodermal cell migration), corroborated by heartstrings mutant data","pmids":["12066188"],"is_preprint":false},{"year":2003,"finding":"Tbx5 is required for forelimb bud initiation in mouse (conditional knockout removes forelimb buds entirely). Additionally, dominant-negative and dominant-activated Tbx5 in chick demonstrate that Tbx5 is required at later stages for continued limb outgrowth. Limb outgrowth and limb identity specification are linked through Tbx5.","method":"Conditional knockout in mouse (forelimb mesenchyme), retroviral dominant-negative and dominant-activated Tbx5 misexpression in chick","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with specific phenotype plus gain/loss-of-function misexpression in second model organism","pmids":["12736217"],"is_preprint":false},{"year":2002,"finding":"Tbx5 promotes limb initiation by functioning downstream of WNT signaling to regulate Fgf10; Fgf10 in turn maintains Tbx5 expression during limb outgrowth. Tbx5 and Wnt2b function together to initiate and specify forelimb outgrowth and identity.","method":"Gain- and loss-of-function experiments in zebrafish and chick; mutant analysis; pathway epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple orthogonal species and experimental approaches establishing pathway order","pmids":["12399308"],"is_preprint":false},{"year":2000,"finding":"Tbx5 misexpression in chick induces dorsalization of the ventral eye and alters retinotectal projection topography, establishing Tbx5 as a topographic determinant for the visual projection between retina and tectum.","method":"Retroviral misexpression of Tbx5 in chick optic vesicle, retinal axon tracing","journal":"Science (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function misexpression with functional axon-projection readout; single lab","pmids":["10615048"],"is_preprint":false},{"year":2000,"finding":"Dominant-negative Tbx5 in Xenopus embryos causes failure of heart development, establishing a global role for Tbx5 in cardiac specification beyond septation. Tbx5 is expressed in the early heart field posterior to Nkx2.5.","method":"Hormone-inducible dominant-negative Tbx5 in Xenopus embryos, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative loss-of-function with organ-level phenotype; single organism, single lab","pmids":["10079235"],"is_preprint":false},{"year":2000,"finding":"Ectopic Tbx5 expression in ventricular myocardium (driven by beta-MHC promoter in transgenic mice) suppresses ventricular-specific gene expression and retards ventricular chamber morphogenesis, demonstrating that Tbx5 directly controls chamber-specific gene programs.","method":"Transgenic mouse overexpression under beta-MHC promoter, molecular marker analysis, histology","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function transgenic with defined gene expression and morphological readouts","pmids":["10864469"],"is_preprint":false},{"year":2001,"finding":"TBX5 inhibits cardiomyocyte proliferation in vitro and in vivo; mutagenesis of the 5' T-box region (G80R) abolishes this anti-proliferative effect. This inhibition includes a non-cell-autonomous component in both cultured cells and transgenic chick hearts.","method":"In vitro overexpression in D17/MEQC cells, transgenic chick heart overexpression, PCNA analysis, co-culture assays","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo overexpression with proliferation readouts and mutagenesis; single lab","pmids":["11161571"],"is_preprint":false},{"year":2003,"finding":"TBX5 misexpression throughout the ventricular myocardium prevents ventricular septum formation (single ventricle) and induces left ventricle-specific gene (ANF) in the right ventricle. A complementary right ventricular factor, chick Tbx20, is repressed by Tbx5 misexpression. Tbx5, Nkx2.5, and GATA4 synergistically activate the human ANF promoter; this is abrogated by Tbx20.","method":"Misexpression in chick and transient transgenic mouse, luciferase reporter assays, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — extensive misexpression experiments in two organisms with molecular epistasis and transcriptional readouts","pmids":["14573514"],"is_preprint":false},{"year":2002,"finding":"Functional analysis of 7 HOS missense mutations shows: G80R, R237Q, R237W dramatically reduce TBX5 DNA-binding activity; Q49K, I54T, G169R, S252I have little effect on DNA binding but abolish synergistic transcriptional activation with NKX2-5. All 7 mutations greatly reduce TBX5-NKX2-5 interaction in vivo and in vitro. Wild-type TBX5 localizes exclusively to nucleus; mutants localize to both nucleus and cytoplasm.","method":"EMSA, co-immunoprecipitation, luciferase reporter assays, immunofluorescent localization in transfected cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (EMSA, co-IP, reporter, localization), comprehensive systematic mutagenesis analysis","pmids":["12499378"],"is_preprint":false},{"year":2004,"finding":"TBX5 transactivating domain maps to amino acids 339-379 (C-terminal); point mutagenesis shows amino acids 349-351 are critical for transactivation. The nuclear localization signal (NLS) is identified as the KRK sequence at amino acids 325-327; deletion mislocalizes TBX5 to the cytoplasm.","method":"GAL4-TBX5 fusion in yeast one-hybrid, deletion mutagenesis, mammalian cell luciferase assays, cellular localization studies","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic deletion and point mutagenesis with functional readout in yeast and mammalian cells; single lab with multiple orthogonal assays","pmids":["15087119"],"is_preprint":false},{"year":2007,"finding":"Tbx5 and Nkx2-5 cooperatively regulate the Id2 promoter (1.2 kb fragment) in vitro, and compound haploinsufficiency of Tbx5/Nkx2-5 or Tbx5/Id2 prevents embryonic specification of the ventricular conduction system, defining a Tbx5-Nkx2-5-Id2 molecular pathway for cardiac conduction system development.","method":"SAGE transcriptional profiling, Id2-null mice analysis, luciferase reporter with Tbx5+Nkx2-5, compound heterozygous mouse crosses, cardiac electrophysiology","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro cooperative transcriptional assay combined with compound genetic epistasis in mouse; multi-lab or multi-pronged study","pmids":["17604724"],"is_preprint":false},{"year":2005,"finding":"Tbx5 and Sall4 interact in a positive and negative feed-forward circuit: Tbx5 regulates Sall4 expression in the developing forelimb and heart; Sall4 heterozygosity produces limb and heart defects. Cooperative and antagonistic interactions between Tbx5 and Sall4 finely regulate patterning and morphogenesis.","method":"Mouse genetics (Sall4 gene trap heterozygotes), gene expression analysis, epistasis experiments, co-expression studies","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis combined with expression analysis in two tissues; identified a feed-forward regulatory circuit","pmids":["16380715"],"is_preprint":false},{"year":2008,"finding":"GATA4 and Tbx5 genetically interact in vivo; compound Gata4/Tbx5 heterozygous mice show near-complete lethality with AV septal defects and myocardial thinning. Gata6 also interacts genetically with Tbx5. The Gata4-Tbx5 genetic interaction operates specifically in the myocardium (not endocardium). Gata4 and Tbx5 directly regulate Cdk4 expression while only Tbx5 activates Cdk2; cardiomyocyte proliferation is defective in compound heterozygotes.","method":"Compound heterozygous mouse crosses, cell-lineage-specific conditional knockouts, co-immunoprecipitation, ChIP, luciferase reporter assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with conditional tissue-specific rescue combined with biochemical ChIP and reporter assays; multiple orthogonal approaches","pmids":["19084512","24858909"],"is_preprint":false},{"year":2005,"finding":"TBX5 and TBX20 physically interact; their interaction domains were mapped. Co-expression of Tbx5 and Tbx20 is not mutually dependent but they act synergistically in early heart development. The C-terminal of Tbx5 is a transcriptional activator while Tbx20 can repress; Tbx20 represses ANF promoter activation by Tbx5.","method":"Morpholino knockdown in Xenopus, co-immunoprecipitation, domain mapping, luciferase reporter assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — physical interaction mapping plus functional synergy established by in vitro reporters and in vivo morpholino phenotypes","pmids":["15634698","14978031"],"is_preprint":false},{"year":2004,"finding":"TBX5 physically interacts with MEF2C through their DNA-binding domains; this interaction leads to synergistic activation of the alpha-cardiac myosin heavy chain (MYH6) promoter. HOS mutations G80R and R279X impair this synergy. Morpholino knockdown of Tbx5 and Mef2c in zebrafish reveals their genetic interaction is required for MYH6 expression and early heart development.","method":"Co-immunoprecipitation, FRET in live cells, luciferase reporter assays, morpholino knockdown in zebrafish","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — FRET demonstrates interaction in living cells; co-IP, reporter assays with mutagenesis, and in vivo genetic validation in zebrafish","pmids":["19204083"],"is_preprint":false},{"year":2004,"finding":"The LMP4/PDLIM7 PDZ-LIM protein binds exclusively to TBX5 and TBX4 (not TBX2 or TBX3) through distinct LIM domains. LMP4 tethers Tbx5 to the actin cytoskeleton and causes Tbx5 to shuttle dynamically between nucleus and cytoplasm, reducing its nuclear transcriptional activity on Fgf10 and ANF promoters. LMP4 acts as a repressor of Tbx5 transcriptional activity.","method":"Yeast two-hybrid, co-immunoprecipitation, subcellular localization (confocal, live cell), luciferase reporter assays, retroviral misexpression in chick","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Y2H, co-IP, live imaging, reporter assays) demonstrating physical interaction and functional consequence; confirmed in vivo","pmids":["16880269","15302601"],"is_preprint":false},{"year":2009,"finding":"Pdlim7/LMP4 regulates TBX5 nuclear/cytoplasmic distribution; Pdlim7 knockdown in zebrafish produces a non-looped heart similar to tbx5 heartstrings mutant. Loss of Pdlim7 causes no valve tissue formation while loss of Tbx5 causes increased valve tissue—opposing defects at the AV boundary. Pdlim7/Tbx5 interactions affect expression of Tbx5 target genes nppa and tbx2b at the AV boundary.","method":"Zebrafish morpholino knockdown, in situ hybridization, histological analysis of valve development","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo morpholino loss-of-function with molecular marker analysis; single lab","pmids":["19895804"],"is_preprint":false},{"year":2006,"finding":"TBX5 is required for embryonic cardiac cell cycle progression; TBX5 depletion causes cell cycle arrest in late G1/early S-phase, reduces cardiac cell number, alters timing of differentiation, impairs sarcomere formation, and causes cardiomyocyte apoptosis. TBX5 is sufficient to determine the length of the embryonic cardiac cell cycle.","method":"TBX5 depletion in Xenopus by morpholino/dominant-negative, flow cytometry cell cycle analysis, TUNEL, immunostaining","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell cycle analysis with loss-of-function in Xenopus with specific cellular phenotypes; single lab","pmids":["16728474"],"is_preprint":false},{"year":2012,"finding":"Tbx5 is required in the second heart field (SHF) for atrial septation; conditional Tbx5 haploinsufficiency in the SHF (but not myocardium or endocardium) causes atrial septal defects. Tbx5 mutant SHF progenitors show cell-cycle progression defects; Tbx5 regulates Cdk6 expression. Activated Hedgehog signaling rescues ASDs in Tbx5 mutant embryos, placing Tbx5 upstream or parallel to Hh in cardiac progenitors. Tbx5 regulates SHF Gas1 and Osr1 expression.","method":"Conditional knockout in mouse (SHF-specific, myocardium-specific, endocardium-specific Cre lines), rescue experiments with activated Hh signaling, cell cycle analysis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with multiple Cre lines and genetic rescue establishing pathway position","pmids":["22898775"],"is_preprint":false},{"year":2012,"finding":"TBX5 directly drives Scn5a (Nav1.5) expression in the ventricular conduction system (VCS) via a TBX5-responsive enhancer downstream of Scn5a dependent on canonical T-box binding sites. Deletion of Tbx5 from mature VCS causes severe conduction defects, arrhythmias, and sudden death without altering VCS fate. Tbx5 also maintains Cx40 expression in the VCS.","method":"Conditional knockout in mature VCS, cardiac electrophysiology, ChIP, enhancer-reporter assay in vivo, T-box binding site mutagenesis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — conditional KO with electrophysiological phenotype, ChIP, and enhancer mutagenesis establishing direct transcriptional target link","pmids":["22728936"],"is_preprint":false},{"year":2010,"finding":"Tbx5 haploinsufficiency in mouse causes impaired ventricular relaxation and reduced SERCA2a (Atp2a2) expression; Tbx5 directly activates the Atp2a2 promoter. Ca2+ uptake dynamics are impaired in Tbx5+/- cardiomyocytes. HOS patients also have diastolic filling abnormalities, defining a direct Tbx5-Atp2a2 pathway regulating cardiac diastolic function.","method":"Tbx5 haploinsufficient mouse model, echocardiography, calcium imaging, luciferase reporter assay with Atp2a2 promoter, human clinical data","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo model with cellular calcium measurements, direct promoter activation assay, and human validation","pmids":["18378906"],"is_preprint":false},{"year":2010,"finding":"Tbx5 is expressed in a subpopulation of endocardial cells; endocardial-specific deletion of Tbx5 causes fully penetrant atrial septal defects via increased apoptosis of Tbx5-null endocardial cells and neighboring Tbx5-positive myocardial cells through activation of endocardial NOS (Nos3). Compound Tbx5/Nos3 haploinsufficiency worsens cardiac phenotype.","method":"Endocardium-specific conditional knockout in mouse, TUNEL apoptosis assay, compound heterozygous crosses, immunohistochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with mechanistic cellular (apoptosis) and genetic (Nos3 interaction) readouts","pmids":["20974940"],"is_preprint":false},{"year":2010,"finding":"Shox2 directly activates Bmp4 gene transcription in the pacemaker region; Tbx5 regulates Shox2 expression in the inflow tract and cooperates with Nkx2.5 to regulate Shox2 and Bmp4, establishing a Tbx5-Shox2-Bmp4 molecular pathway in pacemaker development.","method":"ChIP, luciferase reporter assays, ectopic expression in Xenopus, siRNA knockdown in cardiomyocytes, Tbx5del/+ and Shox2-/- mouse models","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays for Shox2-Bmp4 direct interaction; mouse genetic models for Tbx5 upstream of Shox2; single lab","pmids":["20858598"],"is_preprint":false},{"year":2008,"finding":"A gain-of-function TBX5 p.G125R mutation shows enhanced DNA binding and significantly augmented activation of NPPA, Cx40, Kcnj2, and Tbx3 promoters; maintains normal Nkx2-5 interaction and correct nuclear targeting. This is associated with paroxysmal atrial fibrillation with mild skeletal phenotype, establishing that TBX5 gain-of-function can cause AF.","method":"Luciferase reporter assays, EMSA, co-immunoprecipitation, immunofluorescence localization, clinical family analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple biochemical assays with gain-of-function mutation and clinical correlation; later replicated with mouse knockin model","pmids":["18451335"],"is_preprint":false},{"year":2010,"finding":"TBX5 crystal structure of the T-box domain was solved in both DNA-unbound and DNA-bound forms. A 3(10)-helix at the C-terminus is an inducible recognition element that forms only upon DNA binding. Six HOS mutations in the T-box show reduced thermal stability and reduced DNA-binding affinity; G80R and W121G show the most severe destabilization.","method":"X-ray crystallography, circular dichroism, isothermal titration calorimetry","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of bound and unbound forms combined with thermodynamic measurements of HOS mutants; direct structural mechanism","pmids":["20450920"],"is_preprint":false},{"year":2008,"finding":"Tbx5 generates alternatively spliced isoforms: a full-length 518-aa protein and a shorter C-terminally truncated isoform. The short isoform retains DNA binding but has altered GATA-4 interaction. The two isoforms are oppositely regulated and present in distinct DNA-binding complexes. The long isoform expression correlates with growth stimulation and promotes cardiac hypertrophy when re-expressed in postnatal transgenic mouse hearts.","method":"RT-PCR, co-immunoprecipitation, transgenic mouse overexpression, C2C12 cell overexpression with growth/death assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — alternative splicing demonstrated biochemically with functional consequences in vivo and in vitro; single lab","pmids":["18391012"],"is_preprint":false},{"year":2009,"finding":"Tbx5 directly induces expression of the beta2 CaMK-II (camk2b2) isoform; morpholino knockdown of camk2b2 phenocopies tbx5 morphant cardiac and fin defects (bradycardia, elongated heart, diminished pectoral fins). Ectopic cytosolic CaMK-II expression in tbx5 morphants rescues cardiac phenotype, establishing Tbx5-CaMK-II as a functional pathway in cardiac and fin morphogenesis.","method":"Zebrafish morpholino knockdown of camk2b2 and tbx5, ectopic CaMK-II rescue in tbx5 morphants, overexpression in mouse fibroblasts (CaMK-II quantification), expression analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with genetic rescue experiment establishing functional epistasis; single lab","pmids":["19345202"],"is_preprint":false},{"year":2010,"finding":"Stat3 directly binds the Tbx5 promoter and activates Tbx5 expression in response to gp130 receptor activation; Tbx5 expression is dependent on Stat3 during P19CL6 cardiomyocyte differentiation, placing Stat3 upstream of Tbx5 in cardiac differentiation.","method":"ChIP, luciferase reporter assays, siRNA knockdown of Stat3, P19CL6 differentiation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays with functional KD; single lab","pmids":["20522556"],"is_preprint":false},{"year":2011,"finding":"Myocardin physically interacts with TBX5 through the basic domain of myocardin and the coil domain of Tbx5; they synergistically activate cardiac-specific ANF and alpha-MHC (but not smooth muscle) gene expression in a TBE-binding-site-dependent manner. The HOS mutation Tbx5G80R fails to synergize with myocardin.","method":"Co-immunoprecipitation, luciferase reporter assays, domain mapping, mutagenesis in cell culture","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus reporter assay with domain mapping and disease-mutation validation; single lab","pmids":["21897873"],"is_preprint":false},{"year":2014,"finding":"Foxf1a and Foxf2 are TBX5 target genes in the second heart field: a Foxf1a cis-regulatory element binds TBX5 and GLI1/GLI3 in vivo; GLI1 and TBX5 synergistically activate this element in vitro. This molecular interaction explains the genetic interaction between Tbx5 and Hedgehog signaling for cardiac septation.","method":"Whole-genome transcriptional profiling, GLI-ChIP, TBX5 ChIP, luciferase reporter assays, compound haploinsufficiency mouse crosses","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP identifying direct TBX5 binding to enhancer, combined with in vitro transcriptional synergy and in vivo genetic validation","pmids":["25356765"],"is_preprint":false},{"year":2016,"finding":"Adult-specific deletion of Tbx5 causes spontaneous atrial fibrillation (AF) with action potential abnormalities rescued by calcium chelation. TBX5 directly activates PITX2, and TBX5 and PITX2 antagonistically regulate membrane effector genes Scn5a, Gja1, Ryr2, Dsp, and Atp2a2. Pitx2 haploinsufficiency rescues the AF and gene expression defects caused by Tbx5 haploinsufficiency, defining an incoherent feed-forward loop.","method":"Adult-specific conditional Tbx5 knockout, ECG, action potential recordings, calcium chelation rescue, compound Tbx5/Pitx2 haploinsufficiency, gene expression analysis","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional KO with electrophysiological rescue and compound genetic epistasis defining transcriptional network architecture","pmids":["27582060"],"is_preprint":false},{"year":2018,"finding":"TBX5 directly drives Wnt2 and Wnt2b expression in cardiopulmonary mesoderm via ChIP-identified cis-regulatory elements at Wnt2, initiating a mesoderm-to-endoderm Wnt signaling loop required for pulmonary endoderm specification and subsequent atrial septation. Tbx5 cooperates with Shh signaling to drive Wnt2b for lung morphogenesis.","method":"Conditional Tbx5 knockout in mice, Tbx5 knockdown in amphibians (Xenopus), TBX5 ChIP-sequencing, in vitro Wnt2 promoter assays, enhancer reporter rescue in zebrafish tbx5 mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — TBX5 ChIP-seq identifying direct targets combined with multi-organism genetic models and enhancer functional validation","pmids":["30352852"],"is_preprint":false},{"year":2019,"finding":"TBX5 deficiency causes atrial fibrillation through decreased SERCA2a-mediated SR calcium uptake, balanced by enhanced trans-sarcolemmal calcium fluxes (Ica and NCX), creating triggered activity. Phospholamban removal (which normalizes SERCA function) rescues action potential defects, cardiomyocyte ectopy, and AF, directly linking TBX5 transcriptional control to SERCA2 activity and AF.","method":"Adult-specific conditional Tbx5 knockout, patch clamp electrophysiology, calcium imaging, genetic rescue (phospholamban removal), optical mapping","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with genetic rescue experiment and cellular electrophysiology/calcium imaging identifying specific cellular mechanism","pmids":["30896405"],"is_preprint":false},{"year":2020,"finding":"TBX5 haploinsufficiency in human iPSC-derived cardiomyocytes causes dysregulation of TBX5-dependent pathways in discrete cardiomyocyte subpopulations. A genetic interaction between Tbx5 and Mef2c causing ventricular septation defects was validated in mice, establishing Mef2c as a TBX5 dosage-sensitive cardiac network node.","method":"Human iPSC cardiomyocyte differentiation with TBX5 heterozygous deletion, single-cell RNA-seq, spatial transcriptomics, GRN analysis, compound Tbx5/Mef2c heterozygous mouse validation","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — human iPSC model with single-cell resolution combined with in vivo mouse genetic validation of GRN-predicted interaction","pmids":["33321106"],"is_preprint":false},{"year":2021,"finding":"Tbx5 directly maintains expression of Aldh1a2 (RA-synthesizing enzyme) in the foregut lateral plate mesoderm via an evolutionarily conserved intronic enhancer. Tbx5/Aldh1a2-dependent RA signaling directly activates Shh transcription in the foregut endoderm through a conserved MACS1 enhancer, establishing a Tbx5-RA-Shh-Wnt signaling cascade for cardiopulmonary development.","method":"Xenopus and mouse conditional Tbx5 knockout, TBX5 ChIP on Aldh1a2 enhancer, shh enhancer ChIP, luciferase reporter assays, epistasis experiments","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct ChIP on conserved enhancers, cross-species validation, and pathway epistasis establishing mechanistic cascade","pmids":["34643182"],"is_preprint":false},{"year":2022,"finding":"TBX5 increases SCN5A transcription and represses CAMK2D and SPTBN4; p.F206L TBX5 fails to transactivate SCN5A (loss-of-function causing Brugada syndrome with reduced INa); p.D111Y TBX5 increases SCN5A but fails to repress CAMK2D/SPTBN4, leading to increased late INa and AP prolongation (Long QT syndrome). Ranolazine rescues the QT prolongation in p.D111Y mice.","method":"hiPSC-CM electrophysiology, HL-1 cell assays, transgenic mouse cardiomyocytes, luciferase reporter, ECG, pharmacological rescue","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple experimental systems (hiPSC-CM, HL-1, transgenic mouse), promoter assays, and pharmacological rescue establishing distinct molecular mechanisms for two variants","pmids":["33576403"],"is_preprint":false},{"year":2022,"finding":"The TBX5-p.G125R gain-of-function variant in mice causes atrial arrhythmias with prolonged action potentials, decreased systolic/diastolic Ca2+ concentrations, and profound transcriptional deregulation (>1000 differentially expressed transcripts in cardiomyocytes). Epigenetic profiling shows thousands of TBX5-p.G125R-sensitive regulatory elements with increased chromatin accessibility occupied by Tbx5, suggesting altered DNA binding and cooperativity changes the atrial transcriptional regulatory network.","method":"Mouse knockin of TBX5-G125R, ECG, optical mapping, patch clamp, calcium measurements, single-nucleus RNA-seq, ATAC-seq, H3K27ac CUT&RUN, HiChIP","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — knockin mouse with comprehensive multi-omic profiling (transcriptomics + epigenomics) and electrophysiological characterization","pmids":["35113653"],"is_preprint":false},{"year":2023,"finding":"TBX5 is required in post-natal atrial cardiomyocytes to maintain atrial identity by binding to and preserving the chromatin architecture of atrial-specific enhancers. Atrial-specific Tbx5 KO downregulates atrial cardiomyocyte gene expression; 69% of control-enriched open chromatin regions are TBX5-bound. TBX5 dosage influences 510 chromatin loops including atrial enhancer anchors.","method":"Atrial-specific conditional Tbx5 knockout, single-nucleus RNA-seq plus ATAC-seq, H3K27ac HiChIP chromatin looping","journal":"Nature cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with concurrent epigenomic and transcriptomic profiling at single-nucleus resolution; TBX5 chromatin binding correlated with regulatory element activity","pmids":["38344303"],"is_preprint":false},{"year":2015,"finding":"Tbx5 and Osr1 interact genetically in the posterior SHF to regulate cell cycle progression (specifically G2/M phase entry) for cardiac septation; compound Tbx5/Osr1 haploinsufficiency causes increased AVSDs with reduced Cdk6 expression; disruption of Pten in atrial septum progenitors rescues the AVSDs. Osr1 expression in the pSHF depends on Tbx5 level before E10.5.","method":"Conditional compound haploinsufficiency in mouse, cell cycle analysis, Pten genetic rescue, cell fate mapping, immunohistochemistry","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — compound genetic epistasis with genetic rescue; single lab","pmids":["25986147"],"is_preprint":false},{"year":2016,"finding":"Tbx5 directly regulates Pcsk6 in the posterior SHF as established by ChIP-qPCR and luciferase reporter assay, as part of a gene network module with Osr1 required for atrial septation.","method":"RNA-seq in pSHF of multiple mouse genotypes, ChIP-qPCR, luciferase reporter assay, human genetic study","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay for direct Tbx5-Pcsk6 relationship; supported by in vivo expression analysis; single lab","pmids":["26744331"],"is_preprint":false},{"year":2004,"finding":"TBX5 is expressed throughout the embryonic epicardium and coronary vasculature. Retrovirus-mediated Tbx5 overexpression inhibits proepicardial cell incorporation into the nascent epicardium; antisense knockdown also prevents proepicardial cell migration. This bidirectional sensitivity indicates Tbx5 regulates proepicardial cell migration, and proepicardial cells downregulate Tbx5 during normal migration.","method":"Immunohistochemistry of human embryonic tissue, retroviral overexpression and antisense knockdown in chick PEO, PEO explant culture","journal":"Physiological genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — both gain- and loss-of-function experiments in chick with specific cellular migration phenotype; single lab","pmids":["15138308"],"is_preprint":false},{"year":2014,"finding":"Proepicardial-specific deletion of Tbx5 in mouse impairs epicardial attachment, delays epicardial-derived cell migration, reduces vascular smooth muscle cell recruitment, and causes defective coronary vasculogenesis with myocardial hypoxia and reduced exercise capacity.","method":"Conditional Tbx5 knockout (proepicardial-specific Cre), histology, immunostaining for epicardial-derived cells, HIF-1alpha expression, exercise testing","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined cellular and functional phenotypes (coronary vasculogenesis defect, exercise capacity); confirmed in both chick and mouse","pmids":["25245104"],"is_preprint":false},{"year":2012,"finding":"Loss of Tbx5 in mouse lung mesenchyme leads to unilateral absence of lung bud specification and absence of tracheal specification in organ culture. Double Tbx4/Tbx5 conditional mutants show severe lung branching arrest with downregulation of Wnt2, Fgf10, Bmp4, and Spry2. Tbx4 and Tbx5 interact genetically with Fgf10 during lung growth and branching but not tracheal cartilage development.","method":"Conditional Tbx4/Tbx5 knockout using two different Cre lines, ex vivo organ culture, in situ hybridization, genetic interaction analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with multiple Cre lines, genetic interaction, and organ culture rescue experiments","pmids":["22876201"],"is_preprint":false},{"year":2014,"finding":"A TBX5 enhancer ~90 kb downstream of TBX5 drives heart-restricted expression; a homozygous single-base-pair mutation in this enhancer found in an isolated CHD patient abrogates its ability to drive cardiac expression in both mouse and zebrafish transgenic models, demonstrating that non-coding regulatory mutations in TBX5 enhancers can cause isolated congenital heart disease without limb defects.","method":"Genomic/bioinformatic enhancer scanning, transgenic mouse and zebrafish enhancer reporter assays, enhancer mutation functional testing in vivo","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo enhancer reporter assay in two model organisms with disease mutation functional validation; single patient but two orthogonal transgenic models","pmids":["22543974"],"is_preprint":false},{"year":2004,"finding":"Pax6 physically interacts with Tbx5 and cVax; Pax6 overexpression in chick optic cup expands Tbx5 and Bmp4 domains while reducing cVax. cVax and Tbx5 oppositely modulate Pax6 alpha-enhancer activity; Pax6/cVax interaction inhibits Pax6 transactivation. Together, Pax6, cVax, and Tbx5 mediate dorsoventral patterning of the eye.","method":"In ovo electroporation in chick, co-immunoprecipitation, luciferase reporter assays, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and reporter assays combined with in vivo electroporation; single lab","pmids":["15322073"],"is_preprint":false},{"year":2004,"finding":"TBX5 is autoregulated; ectopically expressed TBX5 increases activity of its own promoter through TBE-B, TBE-C, and NKX2.5 binding sites in the 5'-flanking region. A GC box and T-box-like elements are functionally required for TBX5 promoter activity, as shown by site-directed mutagenesis, DNase footprinting, and EMSA.","method":"Site-directed mutagenesis, DNase I footprinting, EMSA, luciferase reporter assays, transient transfection","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — multiple biochemical methods (EMSA, footprinting, reporter) establishing autoregulation; single lab","pmids":["15095414"],"is_preprint":false},{"year":2021,"finding":"Ventricular-specific Tbx5 deletion in adult mice causes mild cardiac dysfunction, arrhythmias, and high mortality (60%) from sudden cardiac death. RNA-seq and ChIP identify 47 TBX5-controlled transcripts including Gja1, Kcnj5, Kcng2, Cacna1g, Chrm2 (conduction/contraction), Fhl2 (cardioprotection), and cytoskeletal genes. AAV9-mediated TBX5 protein normalization after arrhythmia development re-establishes TBX5-dependent transcriptome, reduces arrhythmia propensity, and ameliorates cardiac dysfunction.","method":"Conditional ventricular Tbx5 KO, RNA-seq, TBX5 ChIP, AAV9 rescue experiment, ECG monitoring","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with ChIP-validated direct targets plus therapeutic rescue experiment demonstrating reversibility","pmids":["32777030"],"is_preprint":false},{"year":2014,"finding":"miR-10a and miR-10b directly target the 3'-UTR of TBX5 to repress TBX5 protein expression, establishing post-transcriptional regulation of TBX5 dosage.","method":"Luciferase 3'-UTR reporter assay, RT-qPCR, Western blot after miRNA mimic/inhibitor transfection","journal":"Pediatric cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3'-UTR reporter assay combined with protein-level validation; single lab","pmids":["24714979"],"is_preprint":false},{"year":2012,"finding":"Hox genes directly regulate Tbx5 forelimb-specific expression; the minimal regulatory element sufficient for forelimb-restricted Tbx5 expression is Hox-responsive. Hoxc9 (expressed in caudal LPM) forms a repressive complex on the Tbx5 forelimb regulatory element through two protein domains, while Hox proteins in rostral LPM form activating complexes, achieving positional restriction of Tbx5.","method":"Transgenic mouse enhancer-reporter assays, electroporation, ChIP, mutagenesis of Hox binding sites, in vitro transcriptional assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — regulatory element identified by transgenic reporter, Hox responsiveness confirmed by multiple approaches including ChIP and mutagenesis","pmids":["22872086","24651482"],"is_preprint":false}],"current_model":"TBX5 is a T-box transcription factor that binds DNA through its T-box domain (crystallographically characterized) and functions as a dosage-sensitive transcriptional activator in heart and limb development by physically interacting with partner transcription factors NKX2-5, GATA4, MEF2C, TBX20, and myocardin to synergistically activate cardiac target genes (including NPPA/ANF, SCN5A/Nav1.5, Cx40, Atp2a2/SERCA2a, Aldh1a2, Wnt2/2b); its nuclear localization is regulated by the LMP4/PDLIM7 cytoskeletal anchor and a defined NLS (KRK at aa325-327); it is required in the second heart field for atrial septation (via a Hedgehog-Foxf-Wnt pathway), in the ventricular conduction system for fast conduction, in the mature atrium for atrial identity maintenance through TBX5-dependent enhancer chromatin architecture, and in the proepicardium for coronary vasculogenesis, while its haploinsufficiency causes HOS and its adult loss or gain-of-function both cause atrial fibrillation through distinct effects on calcium handling (SERCA2a/SR Ca2+ sequestration) and atrial electrophysiology."},"narrative":{"mechanistic_narrative":"TBX5 is a dosage-sensitive T-box transcription factor that orchestrates heart and limb development by binding T-box (Brachyury-type) DNA consensus sites through its T-box domain and activating chamber- and tissue-specific gene programs [PMID:8988165, PMID:11555635, PMID:20450920]. Crystallographic analysis of the T-box domain in DNA-bound and unbound states defines an inducible C-terminal 3(10)-helix recognition element, and HOS-associated T-box mutations reduce thermal stability and DNA-binding affinity [PMID:20450920]; the protein carries a discrete transactivation domain (aa 339–379) and a KRK nuclear localization signal at aa 325–327 [PMID:15087119]. TBX5 functions combinatorially, physically partnering with NKX2-5, GATA4, MEF2C, TBX20, and myocardin to synergistically activate cardiac targets such as NPPA, MYH6, and SCN5A, and disease mutations selectively dissociate DNA binding from these protein–protein synergies [PMID:11431700, PMID:12845333, PMID:12499378, PMID:19204083, PMID:21897873]. In the second heart field it drives atrial septation through a Hedgehog–Foxf–RA–Wnt regulatory cascade and Osr1-dependent progenitor cell-cycle control [PMID:22898775, PMID:25356765, PMID:34643182, PMID:25986147], and in conducting and working myocardium it directly activates Scn5a/Nav1.5, Cx40, and SERCA2a/Atp2a2 to govern fast conduction and calcium handling [PMID:17604724, PMID:22728936, PMID:18378906]. In the mature atrium TBX5 maintains atrial identity by binding and preserving the chromatin architecture of atrial-specific enhancers and loops [PMID:38344303], and operates in an incoherent feed-forward loop with PITX2 to set membrane-effector gene dosage [PMID:27582060]. TBX5 nuclear availability is restrained by the PDLIM7/LMP4 cytoskeletal anchor [PMID:16880269, PMID:15302601], and its transcript dosage is tuned by autoregulation and miR-10-mediated repression [PMID:15095414, PMID:24714979]. Heterozygous loss-of-function mutations cause Holt-Oram syndrome, while distinct adult loss- and gain-of-function alleles drive atrial fibrillation and arrhythmia syndromes through opposing effects on SERCA2a-dependent SR calcium uptake and atrial electrophysiology [PMID:8988165, PMID:18451335, PMID:27582060, PMID:30896405, PMID:35113653].","teleology":[{"year":1997,"claim":"Established TBX5 as a disease gene, linking a single T-box transcription factor to coordinated heart and limb development through haploinsufficiency.","evidence":"Positional cloning and mutation identification in Holt-Oram syndrome pedigrees","pmids":["8988165"],"confidence":"High","gaps":["Did not define molecular targets or partners","Did not explain dosage sensitivity mechanism"]},{"year":1999,"claim":"Showed TBX5 expression is graded and chamber-restricted, providing a spatial basis for the left-sided and septal cardiac defects of HOS.","evidence":"In situ hybridization in mouse and chick hearts correlated with human phenotype","pmids":["10373308"],"confidence":"High","gaps":["Correlative, not functional","Mechanism establishing the gradient not defined"]},{"year":2000,"claim":"Demonstrated TBX5 directly specifies chamber-specific gene programs and global cardiac identity, beyond a role in septation alone.","evidence":"Dominant-negative Tbx5 in Xenopus and beta-MHC-driven ectopic ventricular expression in transgenic mice","pmids":["10079235","10864469"],"confidence":"Medium","gaps":["Direct target genes not yet identified","Single-organism dominant-negative caveats"]},{"year":2001,"claim":"Defined the DNA-binding determinants and the first transcription-factor partner, explaining why distinct HOS mutations cause organ-selective phenotypes.","evidence":"Binding-site selection, EMSA, reporter assays, yeast two-hybrid and co-IP with NKX2-5; structural mapping to the Xbra T-box","pmids":["11555635","11431700","10077612"],"confidence":"High","gaps":["Did not resolve whether DNA-binding and partner-interaction defects are separable","Structural inference based on Xbra not TBX5"]},{"year":2002,"claim":"Systematic mutational analysis separated two failure modes — loss of DNA binding versus loss of NKX2-5 synergy — and showed mutants mislocalize partly to cytoplasm.","evidence":"EMSA, co-IP, reporter assays, and immunofluorescence localization across seven HOS missense mutations","pmids":["12499378"],"confidence":"High","gaps":["Mislocalization mechanism not yet linked to an NLS or anchor","Did not test all partner complexes"]},{"year":2002,"claim":"Defined TBX5 as essential for limb initiation and outgrowth, operating in a WNT→Tbx5→Fgf10 feedback circuit acting on mesodermal cell migration.","evidence":"Zebrafish heartstrings mutant, morpholino knockdown, and gain/loss-of-function epistasis in chick and zebrafish","pmids":["12223419","12066188","12399308"],"confidence":"High","gaps":["Direct limb transcriptional targets not fully mapped","Cross-species relevance to mammalian forelimb assumed"]},{"year":2003,"claim":"Confirmed mammalian requirement for forelimb initiation and identified GATA4 as a second cooperative cardiac partner whose disease mutation disrupts the TBX5 interaction.","evidence":"Conditional mouse forelimb KO with chick misexpression; reciprocal co-IP/pull-down and reporter assays for GATA4","pmids":["12736217","12845333"],"confidence":"High","gaps":["Did not define genome-wide GATA4-TBX5 cobound targets","Quantitative dosage contribution of each partner unclear"]},{"year":2004,"claim":"Mapped functional protein domains (transactivation aa339-379, KRK NLS aa325-327) and identified PDLIM7/LMP4 as a cytoskeletal anchor restraining nuclear TBX5 activity, plus MEF2C as a further partner.","evidence":"Deletion/point mutagenesis, GAL4 fusions, Y2H, co-IP, FRET, live-cell imaging, and reporter assays","pmids":["15087119","15302601","16880269","19204083"],"confidence":"High","gaps":["Physiological signals controlling LMP4-mediated shuttling not defined","Whether anchoring is regulated developmentally unknown"]},{"year":2007,"claim":"Established a TBX5-NKX2-5-Id2 pathway required for ventricular conduction system specification, linking combinatorial transcription to a defined lineage.","evidence":"SAGE profiling, Id2-null mice, reporter assays, compound haploinsufficiency, and electrophysiology","pmids":["17604724"],"confidence":"High","gaps":["Direct genomic Id2 enhancer occupancy in vivo not shown","Downstream conduction effectors not enumerated"]},{"year":2008,"claim":"Revealed that TBX5 gain-of-function (p.G125R) with enhanced DNA binding and target activation causes atrial fibrillation, establishing bidirectional dosage sensitivity, and that alternative splicing modulates GATA4 interaction.","evidence":"Reporter assays, EMSA, co-IP, localization, and clinical family analysis; RT-PCR and transgenic isoform studies","pmids":["18451335","18391012"],"confidence":"High","gaps":["In vivo electrophysiological mechanism of G125R not yet defined (resolved later)","Isoform functional consequences only partially characterized"]},{"year":2010,"claim":"Solved the T-box domain crystal structures and connected direct transcriptional targets (Atp2a2/SERCA2a, Shox2-Bmp4) to TBX5 control of calcium handling and pacemaker development.","evidence":"X-ray crystallography, CD, ITC; Tbx5 haploinsufficient mice with promoter assays, calcium imaging, and ChIP","pmids":["20450920","18378906","20858598","20522556"],"confidence":"High","gaps":["Structure lacked partner-bound complexes","Did not show how single targets integrate into network-level dosage effects"]},{"year":2012,"claim":"Defined direct, enhancer-level control of conduction (Scn5a/Cx40) and progenitor-pathway architecture for atrial septation (Hedgehog parallel role), and a requirement in lung specification.","evidence":"Mature-VCS and second-heart-field conditional KOs, ChIP, enhancer reporter mutagenesis, Hh rescue; conditional Tbx4/Tbx5 lung KO and enhancer-mutation CHD modeling","pmids":["22728936","22898775","22876201","22543974"],"confidence":"High","gaps":["Full set of progenitor cell-cycle effectors incomplete","Tissue-specific cofactors at conduction enhancers not enumerated"]},{"year":2014,"claim":"Connected TBX5 directly to Hedgehog output (Foxf1a via GLI cooperativity) and to proepicardial/coronary vasculogenesis, integrating septation signaling with vascular development.","evidence":"TBX5 and GLI ChIP, reporter synergy, compound haploinsufficiency; proepicardial-specific KO with vascular and exercise phenotypes","pmids":["25356765","25245104"],"confidence":"High","gaps":["Quantitative GLI-TBX5 cooperativity at single enhancers not resolved","Coronary defect's transcriptional targets in epicardium not mapped"]},{"year":2016,"claim":"Defined the incoherent feed-forward loop between TBX5 and its direct target PITX2 that sets atrial membrane-effector dosage, establishing the transcriptional logic underlying atrial fibrillation.","evidence":"Adult conditional Tbx5 KO, ECG, action potential and calcium-chelation rescue, compound Tbx5/Pitx2 epistasis; pSHF ChIP for Pcsk6","pmids":["27582060","26744331"],"confidence":"High","gaps":["Precise stoichiometry of TBX5/PITX2 antagonism at each target unclear","Did not isolate the dominant arrhythmogenic effector"]},{"year":2018,"claim":"Placed TBX5 at the apex of a mesoderm-to-endoderm Wnt2/Wnt2b-RA-Shh signaling cascade required for pulmonary specification and downstream atrial septation.","evidence":"TBX5 ChIP-seq, conditional mouse KO, Xenopus knockdown, enhancer-reporter rescue in zebrafish; RA/Shh enhancer ChIP and epistasis","pmids":["30352852","34643182"],"confidence":"High","gaps":["Feedback between Wnt/RA/Shh loops not fully ordered","Cell-population specificity of each enhancer not resolved"]},{"year":2019,"claim":"Identified the specific cellular mechanism of TBX5-deficient atrial fibrillation: reduced SERCA2a-mediated SR calcium uptake balanced by trans-sarcolemmal flux, generating triggered activity, rescuable by restoring SERCA function.","evidence":"Adult conditional KO with patch clamp, calcium imaging, optical mapping, and phospholamban-removal genetic rescue","pmids":["30896405"],"confidence":"High","gaps":["Did not resolve which transcriptional targets dominate the SR/sarcolemmal imbalance","Translational reversibility window not defined here"]},{"year":2020,"claim":"Resolved TBX5 dosage effects to discrete cardiomyocyte subpopulations and validated MEF2C as a dosage-sensitive network node for ventricular septation using human and mouse genetics.","evidence":"TBX5-heterozygous human iPSC-CMs with single-cell RNA-seq and spatial transcriptomics, GRN analysis, and compound Tbx5/Mef2c mouse validation","pmids":["33321106"],"confidence":"High","gaps":["Subpopulation-specific direct targets not exhaustively mapped","Human-mouse network conservation only partially tested"]},{"year":2021,"claim":"Demonstrated reversibility of TBX5-dependent disease: restoring TBX5 protein after arrhythmia onset re-establishes its direct transcriptome and ameliorates dysfunction, defining ongoing transcriptional maintenance roles.","evidence":"Ventricular conditional KO, RNA-seq, ChIP-validated targets, and AAV9-mediated TBX5 rescue with ECG monitoring","pmids":["32777030"],"confidence":"High","gaps":["Durability and dosage precision of AAV rescue not fully characterized","Mechanism of transcriptome re-establishment at chromatin level not shown here"]},{"year":2022,"claim":"Showed TBX5 maintains adult atrial identity and arrhythmia susceptibility through enhancer chromatin architecture, and that distinct missense variants produce mechanistically separable channelopathies (Brugada, Long QT) via differential SCN5A/CAMK2D control.","evidence":"Atrial- and variant-knockin mouse models, snRNA/ATAC-seq, H3K27ac HiChIP/CUT&RUN, hiPSC-CM and HL-1 electrophysiology, and pharmacological (ranolazine) rescue","pmids":["38344303","35113653","33576403"],"confidence":"High","gaps":["How TBX5 dosage sets specific loop anchors mechanistically unresolved","Generalizability of variant-specific channel mechanisms to other alleles unknown"]},{"year":null,"claim":"How TBX5 mechanistically reads dosage to selectively reconfigure enhancer cooperativity and chromatin looping in a partner- and tissue-specific manner remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structure of TBX5 bound with partner transcription factors on composite enhancers","Mechanism converting small dosage changes into discrete chromatin-architecture shifts not defined","Signals controlling TBX5 nuclear availability in vivo not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,31,26]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,14,16,44]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,16]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[15,22]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[44]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,14,26,44]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,8,25,38,41]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[43,44]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[27,39,53]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,30,37,42]}],"complexes":[],"partners":["NKX2-5","GATA4","MEF2C","TBX20","MYOCD","PDLIM7","PITX2","PAX6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99593","full_name":"T-box transcription factor TBX5","aliases":[],"length_aa":518,"mass_kda":57.7,"function":"DNA-binding protein that regulates the transcription of several genes and is involved in heart development and limb pattern formation (PubMed:25725155, PubMed:25963046, PubMed:26917986, PubMed:27035640, PubMed:29174768, PubMed:8988164). Binds to the core DNA motif of NPPA promoter (PubMed:26926761)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q99593/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TBX5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TBX5","total_profiled":1310},"omim":[{"mim_id":"619589","title":"BRAF-ACTIVATED NONCODING RNA; BANCR","url":"https://www.omim.org/entry/619589"},{"mim_id":"617085","title":"FIN BUD INITIATION FACTOR, ZEBRAFISH, HOMOLOG OF; FIBIN","url":"https://www.omim.org/entry/617085"},{"mim_id":"614954","title":"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3","url":"https://www.omim.org/entry/614954"},{"mim_id":"614089","title":"ATRIAL SEPTAL DEFECT 3; ASD3","url":"https://www.omim.org/entry/614089"},{"mim_id":"610140","title":"HEART-HAND SYNDROME, SLOVENIAN TYPE","url":"https://www.omim.org/entry/610140"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"heart muscle","ntpm":73.6},{"tissue":"lung","ntpm":17.2},{"tissue":"placenta","ntpm":27.0}],"url":"https://www.proteinatlas.org/search/TBX5"},"hgnc":{"alias_symbol":[],"prev_symbol":["HOS"]},"alphafold":{"accession":"Q99593","domains":[{"cath_id":"2.60.40.820","chopping":"43-230","consensus_level":"high","plddt":96.0663,"start":43,"end":230}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99593","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99593-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99593-F1-predicted_aligned_error_v6.png","plddt_mean":62.66},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBX5","jax_strain_url":"https://www.jax.org/strain/search?query=TBX5"},"sequence":{"accession":"Q99593","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99593.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99593/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99593"}},"corpus_meta":[{"pmid":"12845333","id":"PMC_12845333","title":"GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12845333","citation_count":922,"is_preprint":false},{"pmid":"8988165","id":"PMC_8988165","title":"Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome.","date":"1997","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8988165","citation_count":843,"is_preprint":false},{"pmid":"8853987","id":"PMC_8853987","title":"Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development.","date":"1996","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/8853987","citation_count":531,"is_preprint":false},{"pmid":"11431700","id":"PMC_11431700","title":"Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11431700","citation_count":455,"is_preprint":false},{"pmid":"10373308","id":"PMC_10373308","title":"Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10373308","citation_count":374,"is_preprint":false},{"pmid":"10077612","id":"PMC_10077612","title":"Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10077612","citation_count":282,"is_preprint":false},{"pmid":"12223419","id":"PMC_12223419","title":"The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12223419","citation_count":237,"is_preprint":false},{"pmid":"10235264","id":"PMC_10235264","title":"The T-box genes Tbx4 and Tbx5 regulate limb outgrowth and identity.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10235264","citation_count":234,"is_preprint":false},{"pmid":"17604724","id":"PMC_17604724","title":"A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17604724","citation_count":223,"is_preprint":false},{"pmid":"22931955","id":"PMC_22931955","title":"Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.","date":"2012","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/22931955","citation_count":212,"is_preprint":false},{"pmid":"10615048","id":"PMC_10615048","title":"Tbx5 and the retinotectum projection.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10615048","citation_count":205,"is_preprint":false},{"pmid":"10235263","id":"PMC_10235263","title":"Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10235263","citation_count":205,"is_preprint":false},{"pmid":"25416133","id":"PMC_25416133","title":"Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming.","date":"2014","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/25416133","citation_count":194,"is_preprint":false},{"pmid":"12736217","id":"PMC_12736217","title":"Tbx5 is required for forelimb bud formation and continued outgrowth.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12736217","citation_count":189,"is_preprint":false},{"pmid":"12399308","id":"PMC_12399308","title":"The limb identity gene Tbx5 promotes limb initiation by interacting with Wnt2b and Fgf10.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12399308","citation_count":183,"is_preprint":false},{"pmid":"10079235","id":"PMC_10079235","title":"Tbx5 is essential for heart development.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10079235","citation_count":183,"is_preprint":false},{"pmid":"12066188","id":"PMC_12066188","title":"T-box gene tbx5 is essential for formation of the pectoral limb bud.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12066188","citation_count":179,"is_preprint":false},{"pmid":"11087629","id":"PMC_11087629","title":"Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx2.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11087629","citation_count":171,"is_preprint":false},{"pmid":"22543974","id":"PMC_22543974","title":"Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22543974","citation_count":170,"is_preprint":false},{"pmid":"19084512","id":"PMC_19084512","title":"Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19084512","citation_count":160,"is_preprint":false},{"pmid":"22876201","id":"PMC_22876201","title":"Multiple roles and interactions of Tbx4 and Tbx5 in development of the respiratory system.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22876201","citation_count":158,"is_preprint":false},{"pmid":"10864469","id":"PMC_10864469","title":"Ventricular expression of tbx5 inhibits normal heart chamber development.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10864469","citation_count":154,"is_preprint":false},{"pmid":"18451335","id":"PMC_18451335","title":"A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation.","date":"2008","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18451335","citation_count":145,"is_preprint":false},{"pmid":"9609833","id":"PMC_9609833","title":"Involvement of T-box genes Tbx2-Tbx5 in vertebrate limb specification and development.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9609833","citation_count":144,"is_preprint":false},{"pmid":"9651516","id":"PMC_9651516","title":"Expression of T-box genes Tbx2-Tbx5 during chick organogenesis.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9651516","citation_count":140,"is_preprint":false},{"pmid":"16380715","id":"PMC_16380715","title":"Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16380715","citation_count":137,"is_preprint":false},{"pmid":"14573514","id":"PMC_14573514","title":"Tbx5 specifies the left/right ventricles and ventricular septum position during cardiogenesis.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14573514","citation_count":133,"is_preprint":false},{"pmid":"23704920","id":"PMC_23704920","title":"Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23704920","citation_count":127,"is_preprint":false},{"pmid":"22898775","id":"PMC_22898775","title":"Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation.","date":"2012","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/22898775","citation_count":125,"is_preprint":false},{"pmid":"22728936","id":"PMC_22728936","title":"TBX5 drives Scn5a expression to regulate cardiac conduction system function.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/22728936","citation_count":124,"is_preprint":false},{"pmid":"15096952","id":"PMC_15096952","title":"TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed.","date":"2004","source":"Current opinion in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/15096952","citation_count":123,"is_preprint":false},{"pmid":"27582060","id":"PMC_27582060","title":"Pitx2 modulates a Tbx5-dependent gene regulatory network to maintain atrial rhythm.","date":"2016","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27582060","citation_count":123,"is_preprint":false},{"pmid":"11555635","id":"PMC_11555635","title":"Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11555635","citation_count":120,"is_preprint":false},{"pmid":"15621531","id":"PMC_15621531","title":"Tbx5 and Tbx4 are not sufficient to determine limb-specific morphologies but have common roles in initiating limb outgrowth.","date":"2005","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/15621531","citation_count":119,"is_preprint":false},{"pmid":"15634698","id":"PMC_15634698","title":"Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15634698","citation_count":114,"is_preprint":false},{"pmid":"14978031","id":"PMC_14978031","title":"Differential expression and function of Tbx5 and Tbx20 in cardiac development.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14978031","citation_count":107,"is_preprint":false},{"pmid":"16183809","id":"PMC_16183809","title":"TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome.","date":"2005","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/16183809","citation_count":101,"is_preprint":false},{"pmid":"19204083","id":"PMC_19204083","title":"Physical interaction between TBX5 and MEF2C is required for early heart development.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19204083","citation_count":97,"is_preprint":false},{"pmid":"9389663","id":"PMC_9389663","title":"Correlation of wing-leg identity in ectopic FGF-induced chimeric limbs with the differential expression of chick Tbx5 and Tbx4.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9389663","citation_count":97,"is_preprint":false},{"pmid":"11161571","id":"PMC_11161571","title":"TBX5 transcription factor regulates cell proliferation during cardiogenesis.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11161571","citation_count":96,"is_preprint":false},{"pmid":"25447851","id":"PMC_25447851","title":"Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.","date":"2014","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25447851","citation_count":92,"is_preprint":false},{"pmid":"12789647","id":"PMC_12789647","title":"Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12789647","citation_count":92,"is_preprint":false},{"pmid":"33321106","id":"PMC_33321106","title":"Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease.","date":"2020","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/33321106","citation_count":91,"is_preprint":false},{"pmid":"20858598","id":"PMC_20858598","title":"Shox2 mediates Tbx5 activity by regulating Bmp4 in the pacemaker region of the developing heart.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20858598","citation_count":91,"is_preprint":false},{"pmid":"12499378","id":"PMC_12499378","title":"Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12499378","citation_count":90,"is_preprint":false},{"pmid":"15138308","id":"PMC_15138308","title":"A role for Tbx5 in proepicardial cell migration during cardiogenesis.","date":"2004","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15138308","citation_count":76,"is_preprint":false},{"pmid":"22011241","id":"PMC_22011241","title":"Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: multiple heterozygosity and novel mutations.","date":"2011","source":"Congenital heart disease","url":"https://pubmed.ncbi.nlm.nih.gov/22011241","citation_count":75,"is_preprint":false},{"pmid":"15221798","id":"PMC_15221798","title":"TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15221798","citation_count":73,"is_preprint":false},{"pmid":"25356765","id":"PMC_25356765","title":"Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25356765","citation_count":72,"is_preprint":false},{"pmid":"10974675","id":"PMC_10974675","title":"Identification and localization of TBX5 transcription factor during human cardiac morphogenesis.","date":"2000","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10974675","citation_count":69,"is_preprint":false},{"pmid":"10704879","id":"PMC_10704879","title":"Conserved and divergent expression of T-box genes Tbx2-Tbx5 in Xenopus.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10704879","citation_count":68,"is_preprint":false},{"pmid":"22872086","id":"PMC_22872086","title":"Hox genes regulate the onset of Tbx5 expression in the forelimb.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22872086","citation_count":65,"is_preprint":false},{"pmid":"15302601","id":"PMC_15302601","title":"Tbx5 and Tbx4 transcription factors interact with a new chicken PDZ-LIM protein in limb and heart development.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15302601","citation_count":62,"is_preprint":false},{"pmid":"20974940","id":"PMC_20974940","title":"An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20974940","citation_count":60,"is_preprint":false},{"pmid":"16728474","id":"PMC_16728474","title":"TBX5 is required for embryonic cardiac cell cycle progression.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16728474","citation_count":58,"is_preprint":false},{"pmid":"18378906","id":"PMC_18378906","title":"Tbx5-dependent pathway regulating diastolic function in congenital heart disease.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18378906","citation_count":56,"is_preprint":false},{"pmid":"10495283","id":"PMC_10495283","title":"Differential expression of Tbx4 and Tbx5 in Zebrafish fin buds.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10495283","citation_count":55,"is_preprint":false},{"pmid":"30352852","id":"PMC_30352852","title":"Evolutionarily conserved Tbx5-Wnt2/2b pathway orchestrates cardiopulmonary development.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30352852","citation_count":54,"is_preprint":false},{"pmid":"24858909","id":"PMC_24858909","title":"Disruption of myocardial Gata4 and Tbx5 results in defects in cardiomyocyte proliferation and atrioventricular septation.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24858909","citation_count":52,"is_preprint":false},{"pmid":"16501170","id":"PMC_16501170","title":"sall4 acts downstream of tbx5 and is required for pectoral fin outgrowth.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16501170","citation_count":52,"is_preprint":false},{"pmid":"20522556","id":"PMC_20522556","title":"Stat3 directly controls the expression of Tbx5, Nkx2.5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20522556","citation_count":48,"is_preprint":false},{"pmid":"19895804","id":"PMC_19895804","title":"Pdlim7 (LMP4) regulation of Tbx5 specifies zebrafish heart atrio-ventricular boundary and valve formation.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19895804","citation_count":47,"is_preprint":false},{"pmid":"28782180","id":"PMC_28782180","title":"Down-regulation of miR-10a-5p in synoviocytes contributes to TBX5-controlled joint inflammation.","date":"2017","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28782180","citation_count":46,"is_preprint":false},{"pmid":"25263169","id":"PMC_25263169","title":"Identification of TBX5 mutations in a series of 94 patients with Tetralogy of Fallot.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25263169","citation_count":46,"is_preprint":false},{"pmid":"25725155","id":"PMC_25725155","title":"TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25725155","citation_count":45,"is_preprint":false},{"pmid":"25680289","id":"PMC_25680289","title":"Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25680289","citation_count":44,"is_preprint":false},{"pmid":"20450920","id":"PMC_20450920","title":"Structural basis of TBX5-DNA recognition: the T-box domain in its DNA-bound and -unbound form.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20450920","citation_count":43,"is_preprint":false},{"pmid":"18391012","id":"PMC_18391012","title":"Distinct expression and function of alternatively spliced Tbx5 isoforms in cell growth and differentiation.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18391012","citation_count":42,"is_preprint":false},{"pmid":"12376111","id":"PMC_12376111","title":"Different regulation of T-box genes Tbx4 and Tbx5 during limb development and limb regeneration.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12376111","citation_count":41,"is_preprint":false},{"pmid":"15087119","id":"PMC_15087119","title":"Identification of the TBX5 transactivating domain and the nuclear localization signal.","date":"2004","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15087119","citation_count":40,"is_preprint":false},{"pmid":"24651482","id":"PMC_24651482","title":"A combination of activation and repression by a colinear Hox code controls forelimb-restricted expression of Tbx5 and reveals Hox protein specificity.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24651482","citation_count":40,"is_preprint":false},{"pmid":"26762269","id":"PMC_26762269","title":"TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.","date":"2016","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/26762269","citation_count":39,"is_preprint":false},{"pmid":"25468972","id":"PMC_25468972","title":"Regulatory modulation of the T-box gene Tbx5 links development, evolution, and adaptation of the sternum.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25468972","citation_count":38,"is_preprint":false},{"pmid":"25986147","id":"PMC_25986147","title":"Tbx5 and Osr1 interact to regulate posterior second heart field cell cycle progression for cardiac septation.","date":"2015","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25986147","citation_count":37,"is_preprint":false},{"pmid":"30896405","id":"PMC_30896405","title":"A calcium transport mechanism for atrial fibrillation in Tbx5-mutant mice.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30896405","citation_count":37,"is_preprint":false},{"pmid":"30552424","id":"PMC_30552424","title":"Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants.","date":"2018","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/30552424","citation_count":37,"is_preprint":false},{"pmid":"10842287","id":"PMC_10842287","title":"Three novel TBX5 mutations in Chinese patients with Holt-Oram syndrome.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10842287","citation_count":37,"is_preprint":false},{"pmid":"15322073","id":"PMC_15322073","title":"Pax6 interacts with cVax and Tbx5 to establish the dorsoventral boundary of the developing eye.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15322073","citation_count":37,"is_preprint":false},{"pmid":"35113653","id":"PMC_35113653","title":"Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.","date":"2022","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/35113653","citation_count":34,"is_preprint":false},{"pmid":"27503876","id":"PMC_27503876","title":"Regulatory evolution of Tbx5 and the origin of paired appendages.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27503876","citation_count":34,"is_preprint":false},{"pmid":"19345202","id":"PMC_19345202","title":"Tbx5-mediated expression of Ca(2+)/calmodulin-dependent protein kinase II is necessary for zebrafish cardiac and pectoral fin morphogenesis.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19345202","citation_count":33,"is_preprint":false},{"pmid":"25245104","id":"PMC_25245104","title":"Tbx5 is required for avian and Mammalian epicardial formation and coronary vasculogenesis.","date":"2014","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/25245104","citation_count":32,"is_preprint":false},{"pmid":"16880269","id":"PMC_16880269","title":"LMP4 regulates Tbx5 protein subcellular localization and activity.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16880269","citation_count":31,"is_preprint":false},{"pmid":"16134140","id":"PMC_16134140","title":"The human TBX5 gene mutation database.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16134140","citation_count":30,"is_preprint":false},{"pmid":"25963046","id":"PMC_25963046","title":"A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25963046","citation_count":30,"is_preprint":false},{"pmid":"21897873","id":"PMC_21897873","title":"Synergistic activation of cardiac genes by myocardin and Tbx5.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21897873","citation_count":30,"is_preprint":false},{"pmid":"34750102","id":"PMC_34750102","title":"Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.","date":"2021","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34750102","citation_count":30,"is_preprint":false},{"pmid":"28469241","id":"PMC_28469241","title":"A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28469241","citation_count":29,"is_preprint":false},{"pmid":"23441045","id":"PMC_23441045","title":"Zebrafish tbx5 paralogs demonstrate independent essential requirements in cardiac and pectoral fin development.","date":"2013","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23441045","citation_count":29,"is_preprint":false},{"pmid":"32344431","id":"PMC_32344431","title":"Mutations Upstream of the TBX5 and PITX1 Transcription Factor Genes Are Associated with Feathered Legs in the Domestic Chicken.","date":"2020","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/32344431","citation_count":29,"is_preprint":false},{"pmid":"23144723","id":"PMC_23144723","title":"Cardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and Myocd.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23144723","citation_count":29,"is_preprint":false},{"pmid":"16477648","id":"PMC_16477648","title":"Developmental expression patterns of Tbx1, Tbx2, Tbx5, and Tbx20 in Xenopus tropicalis.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16477648","citation_count":28,"is_preprint":false},{"pmid":"26744331","id":"PMC_26744331","title":"Gene network and familial analyses uncover a gene network involving Tbx5/Osr1/Pcsk6 interaction in the second heart field for atrial septation.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26744331","citation_count":28,"is_preprint":false},{"pmid":"15095414","id":"PMC_15095414","title":"TBX5, a gene mutated in Holt-Oram syndrome, is regulated through a GC box and T-box binding elements (TBEs).","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15095414","citation_count":27,"is_preprint":false},{"pmid":"33576403","id":"PMC_33576403","title":"Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/33576403","citation_count":26,"is_preprint":false},{"pmid":"19925885","id":"PMC_19925885","title":"Identification and characterisation of the developmental expression pattern of tbx5b, a novel tbx5 gene in zebrafish.","date":"2009","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/19925885","citation_count":26,"is_preprint":false},{"pmid":"38344303","id":"PMC_38344303","title":"Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network.","date":"2023","source":"Nature cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/38344303","citation_count":25,"is_preprint":false},{"pmid":"32777030","id":"PMC_32777030","title":"Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.","date":"2021","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/32777030","citation_count":25,"is_preprint":false},{"pmid":"24714979","id":"PMC_24714979","title":"miR-10a and miR-10b target the 3'-untranslated region of TBX5 to repress its expression.","date":"2014","source":"Pediatric cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24714979","citation_count":25,"is_preprint":false},{"pmid":"34643182","id":"PMC_34643182","title":"Tbx5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34643182","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49111,"output_tokens":14200,"usd":0.180167,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":26380,"output_tokens":6068,"usd":0.1418,"stage2_stop_reason":"end_turn"},"total_usd":0.321967,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"TBX5 is a T-box transcription factor whose mutations (including nonsense and missense mutations) cause Holt-Oram syndrome, establishing TBX5 as critical for limb and heart development; haploinsufficiency of TBX5 is sufficient to cause the syndrome.\",\n      \"method\": \"Genetic cloning, mutation identification in affected pedigrees, positional mapping to chromosome 12q24.1\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational disease gene identification replicated across multiple pedigrees and subsequently confirmed by many independent labs\",\n      \"pmids\": [\"8988165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TBX5 physically interacts with NKX2-5 (cardiac homeobox protein); the interaction requires the N-terminal domain and N-terminal T-box of TBX5 and the homeodomain of NKX2-5. TBX5 and NKX2-5 together synergistically activate the NPPA (ANF) promoter. The HOS-causing cardiac missense mutation G80R abolishes this synergy, while the limb-predominant R237Q mutation does not.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation in COS-7 cells, co-transfection/luciferase reporter assays, overexpression in P19CL6 cells with functional differentiation readout\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (yeast two-hybrid, GST pull-down, co-IP, reporter assays, cell differentiation), replicated by independent labs\",\n      \"pmids\": [\"11431700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GATA4 physically interacts with TBX5; a HOS-associated GATA4 G296S missense mutation abrogates this interaction. Specific HOS-causing TBX5 missense mutations similarly disrupt the GATA4-TBX5 physical interaction, indicating cooperative transcriptional activation through this complex.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, luciferase transcriptional assays, genetic linkage and sequencing\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP and pull-down, replicated with multiple disease-causing mutations, independently confirmed by subsequent studies\",\n      \"pmids\": [\"12845333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TBX5 is expressed in a graded fashion in the developing heart: strong posteriorly and in the left ventricle but absent from the right ventricle and outflow tract. This chamber-specific expression pattern correlates with the cardiac defects observed in HOS (atrial septal defects, left-sided malformations).\",\n      \"method\": \"In situ hybridization in developing mouse and chick hearts; correlation with human HOS cardiac phenotype\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization with functional consequence (chamber-specific phenotype prediction), replicated across species and confirmed by subsequent functional studies\",\n      \"pmids\": [\"10373308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HOS missense mutations at residue 80 (Gly80Arg) primarily cause cardiac malformations whereas mutations at residue 237 (Arg237Gln/Trp) primarily cause skeletal malformations; structural mapping to the Xbra T-box showed residue 80 contacts the major groove of target DNA while residue 237 contacts the minor groove, suggesting organ-specific TBX5 activity depends on biophysical interactions with different target DNA sequences.\",\n      \"method\": \"Clinical phenotype analysis of 10 HOS mutations correlated with structural modeling of TBX5 T-box based on Xbra crystal structure\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — phenotype-mutation correlation supported by structural inference; mechanistic model replicated by later biochemical studies\",\n      \"pmids\": [\"10077612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TBX5 binds a specific 8 bp core DNA sequence (part of the Brachyury consensus binding site) including the full palindromic and half-palindrome Brachyury sites; amino acids 1-237 are required for DNA binding. HOS mutations G80R and R237Q eliminate binding to target DNA. TBX5 activates an ANF reporter construct in a T-box binding-site-dependent manner.\",\n      \"method\": \"In vitro binding site selection assay, EMSA, cell transfection/luciferase reporter, mutational analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding assay with mutagenesis and functional transcriptional readout; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11555635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Zebrafish tbx5 (heartstrings mutation, premature stop at aa316) is required for pectoral fin bud formation and for cardiac looping morphogenesis; homozygous mutants lack pectoral fins entirely and show progressive cardiac deterioration. Tbx5 functions very early in pectoral fin induction and coordinates fin outgrowth axes.\",\n      \"method\": \"Forward genetic screen, positional cloning, morpholino knockdown, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function allele combined with morpholino experiments; defined cellular phenotypes; ortholog confirmed\",\n      \"pmids\": [\"12223419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tbx5 is required for formation of the pectoral fin bud in zebrafish; morpholino knockdown results in complete loss of pectoral fins through a defect in directed migration of lateral plate mesodermal cells into the limb-bud-producing region.\",\n      \"method\": \"Antisense morpholino knockdown, histological analysis of mesodermal cell migration in zebrafish\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — morpholino loss-of-function with cellular phenotype (mesodermal cell migration), corroborated by heartstrings mutant data\",\n      \"pmids\": [\"12066188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Tbx5 is required for forelimb bud initiation in mouse (conditional knockout removes forelimb buds entirely). Additionally, dominant-negative and dominant-activated Tbx5 in chick demonstrate that Tbx5 is required at later stages for continued limb outgrowth. Limb outgrowth and limb identity specification are linked through Tbx5.\",\n      \"method\": \"Conditional knockout in mouse (forelimb mesenchyme), retroviral dominant-negative and dominant-activated Tbx5 misexpression in chick\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with specific phenotype plus gain/loss-of-function misexpression in second model organism\",\n      \"pmids\": [\"12736217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tbx5 promotes limb initiation by functioning downstream of WNT signaling to regulate Fgf10; Fgf10 in turn maintains Tbx5 expression during limb outgrowth. Tbx5 and Wnt2b function together to initiate and specify forelimb outgrowth and identity.\",\n      \"method\": \"Gain- and loss-of-function experiments in zebrafish and chick; mutant analysis; pathway epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple orthogonal species and experimental approaches establishing pathway order\",\n      \"pmids\": [\"12399308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Tbx5 misexpression in chick induces dorsalization of the ventral eye and alters retinotectal projection topography, establishing Tbx5 as a topographic determinant for the visual projection between retina and tectum.\",\n      \"method\": \"Retroviral misexpression of Tbx5 in chick optic vesicle, retinal axon tracing\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function misexpression with functional axon-projection readout; single lab\",\n      \"pmids\": [\"10615048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Dominant-negative Tbx5 in Xenopus embryos causes failure of heart development, establishing a global role for Tbx5 in cardiac specification beyond septation. Tbx5 is expressed in the early heart field posterior to Nkx2.5.\",\n      \"method\": \"Hormone-inducible dominant-negative Tbx5 in Xenopus embryos, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative loss-of-function with organ-level phenotype; single organism, single lab\",\n      \"pmids\": [\"10079235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Ectopic Tbx5 expression in ventricular myocardium (driven by beta-MHC promoter in transgenic mice) suppresses ventricular-specific gene expression and retards ventricular chamber morphogenesis, demonstrating that Tbx5 directly controls chamber-specific gene programs.\",\n      \"method\": \"Transgenic mouse overexpression under beta-MHC promoter, molecular marker analysis, histology\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function transgenic with defined gene expression and morphological readouts\",\n      \"pmids\": [\"10864469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TBX5 inhibits cardiomyocyte proliferation in vitro and in vivo; mutagenesis of the 5' T-box region (G80R) abolishes this anti-proliferative effect. This inhibition includes a non-cell-autonomous component in both cultured cells and transgenic chick hearts.\",\n      \"method\": \"In vitro overexpression in D17/MEQC cells, transgenic chick heart overexpression, PCNA analysis, co-culture assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo overexpression with proliferation readouts and mutagenesis; single lab\",\n      \"pmids\": [\"11161571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TBX5 misexpression throughout the ventricular myocardium prevents ventricular septum formation (single ventricle) and induces left ventricle-specific gene (ANF) in the right ventricle. A complementary right ventricular factor, chick Tbx20, is repressed by Tbx5 misexpression. Tbx5, Nkx2.5, and GATA4 synergistically activate the human ANF promoter; this is abrogated by Tbx20.\",\n      \"method\": \"Misexpression in chick and transient transgenic mouse, luciferase reporter assays, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — extensive misexpression experiments in two organisms with molecular epistasis and transcriptional readouts\",\n      \"pmids\": [\"14573514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Functional analysis of 7 HOS missense mutations shows: G80R, R237Q, R237W dramatically reduce TBX5 DNA-binding activity; Q49K, I54T, G169R, S252I have little effect on DNA binding but abolish synergistic transcriptional activation with NKX2-5. All 7 mutations greatly reduce TBX5-NKX2-5 interaction in vivo and in vitro. Wild-type TBX5 localizes exclusively to nucleus; mutants localize to both nucleus and cytoplasm.\",\n      \"method\": \"EMSA, co-immunoprecipitation, luciferase reporter assays, immunofluorescent localization in transfected cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (EMSA, co-IP, reporter, localization), comprehensive systematic mutagenesis analysis\",\n      \"pmids\": [\"12499378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TBX5 transactivating domain maps to amino acids 339-379 (C-terminal); point mutagenesis shows amino acids 349-351 are critical for transactivation. The nuclear localization signal (NLS) is identified as the KRK sequence at amino acids 325-327; deletion mislocalizes TBX5 to the cytoplasm.\",\n      \"method\": \"GAL4-TBX5 fusion in yeast one-hybrid, deletion mutagenesis, mammalian cell luciferase assays, cellular localization studies\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic deletion and point mutagenesis with functional readout in yeast and mammalian cells; single lab with multiple orthogonal assays\",\n      \"pmids\": [\"15087119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Tbx5 and Nkx2-5 cooperatively regulate the Id2 promoter (1.2 kb fragment) in vitro, and compound haploinsufficiency of Tbx5/Nkx2-5 or Tbx5/Id2 prevents embryonic specification of the ventricular conduction system, defining a Tbx5-Nkx2-5-Id2 molecular pathway for cardiac conduction system development.\",\n      \"method\": \"SAGE transcriptional profiling, Id2-null mice analysis, luciferase reporter with Tbx5+Nkx2-5, compound heterozygous mouse crosses, cardiac electrophysiology\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro cooperative transcriptional assay combined with compound genetic epistasis in mouse; multi-lab or multi-pronged study\",\n      \"pmids\": [\"17604724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tbx5 and Sall4 interact in a positive and negative feed-forward circuit: Tbx5 regulates Sall4 expression in the developing forelimb and heart; Sall4 heterozygosity produces limb and heart defects. Cooperative and antagonistic interactions between Tbx5 and Sall4 finely regulate patterning and morphogenesis.\",\n      \"method\": \"Mouse genetics (Sall4 gene trap heterozygotes), gene expression analysis, epistasis experiments, co-expression studies\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis combined with expression analysis in two tissues; identified a feed-forward regulatory circuit\",\n      \"pmids\": [\"16380715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GATA4 and Tbx5 genetically interact in vivo; compound Gata4/Tbx5 heterozygous mice show near-complete lethality with AV septal defects and myocardial thinning. Gata6 also interacts genetically with Tbx5. The Gata4-Tbx5 genetic interaction operates specifically in the myocardium (not endocardium). Gata4 and Tbx5 directly regulate Cdk4 expression while only Tbx5 activates Cdk2; cardiomyocyte proliferation is defective in compound heterozygotes.\",\n      \"method\": \"Compound heterozygous mouse crosses, cell-lineage-specific conditional knockouts, co-immunoprecipitation, ChIP, luciferase reporter assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with conditional tissue-specific rescue combined with biochemical ChIP and reporter assays; multiple orthogonal approaches\",\n      \"pmids\": [\"19084512\", \"24858909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TBX5 and TBX20 physically interact; their interaction domains were mapped. Co-expression of Tbx5 and Tbx20 is not mutually dependent but they act synergistically in early heart development. The C-terminal of Tbx5 is a transcriptional activator while Tbx20 can repress; Tbx20 represses ANF promoter activation by Tbx5.\",\n      \"method\": \"Morpholino knockdown in Xenopus, co-immunoprecipitation, domain mapping, luciferase reporter assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — physical interaction mapping plus functional synergy established by in vitro reporters and in vivo morpholino phenotypes\",\n      \"pmids\": [\"15634698\", \"14978031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TBX5 physically interacts with MEF2C through their DNA-binding domains; this interaction leads to synergistic activation of the alpha-cardiac myosin heavy chain (MYH6) promoter. HOS mutations G80R and R279X impair this synergy. Morpholino knockdown of Tbx5 and Mef2c in zebrafish reveals their genetic interaction is required for MYH6 expression and early heart development.\",\n      \"method\": \"Co-immunoprecipitation, FRET in live cells, luciferase reporter assays, morpholino knockdown in zebrafish\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — FRET demonstrates interaction in living cells; co-IP, reporter assays with mutagenesis, and in vivo genetic validation in zebrafish\",\n      \"pmids\": [\"19204083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The LMP4/PDLIM7 PDZ-LIM protein binds exclusively to TBX5 and TBX4 (not TBX2 or TBX3) through distinct LIM domains. LMP4 tethers Tbx5 to the actin cytoskeleton and causes Tbx5 to shuttle dynamically between nucleus and cytoplasm, reducing its nuclear transcriptional activity on Fgf10 and ANF promoters. LMP4 acts as a repressor of Tbx5 transcriptional activity.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, subcellular localization (confocal, live cell), luciferase reporter assays, retroviral misexpression in chick\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Y2H, co-IP, live imaging, reporter assays) demonstrating physical interaction and functional consequence; confirmed in vivo\",\n      \"pmids\": [\"16880269\", \"15302601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pdlim7/LMP4 regulates TBX5 nuclear/cytoplasmic distribution; Pdlim7 knockdown in zebrafish produces a non-looped heart similar to tbx5 heartstrings mutant. Loss of Pdlim7 causes no valve tissue formation while loss of Tbx5 causes increased valve tissue—opposing defects at the AV boundary. Pdlim7/Tbx5 interactions affect expression of Tbx5 target genes nppa and tbx2b at the AV boundary.\",\n      \"method\": \"Zebrafish morpholino knockdown, in situ hybridization, histological analysis of valve development\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo morpholino loss-of-function with molecular marker analysis; single lab\",\n      \"pmids\": [\"19895804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TBX5 is required for embryonic cardiac cell cycle progression; TBX5 depletion causes cell cycle arrest in late G1/early S-phase, reduces cardiac cell number, alters timing of differentiation, impairs sarcomere formation, and causes cardiomyocyte apoptosis. TBX5 is sufficient to determine the length of the embryonic cardiac cell cycle.\",\n      \"method\": \"TBX5 depletion in Xenopus by morpholino/dominant-negative, flow cytometry cell cycle analysis, TUNEL, immunostaining\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell cycle analysis with loss-of-function in Xenopus with specific cellular phenotypes; single lab\",\n      \"pmids\": [\"16728474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Tbx5 is required in the second heart field (SHF) for atrial septation; conditional Tbx5 haploinsufficiency in the SHF (but not myocardium or endocardium) causes atrial septal defects. Tbx5 mutant SHF progenitors show cell-cycle progression defects; Tbx5 regulates Cdk6 expression. Activated Hedgehog signaling rescues ASDs in Tbx5 mutant embryos, placing Tbx5 upstream or parallel to Hh in cardiac progenitors. Tbx5 regulates SHF Gas1 and Osr1 expression.\",\n      \"method\": \"Conditional knockout in mouse (SHF-specific, myocardium-specific, endocardium-specific Cre lines), rescue experiments with activated Hh signaling, cell cycle analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with multiple Cre lines and genetic rescue establishing pathway position\",\n      \"pmids\": [\"22898775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TBX5 directly drives Scn5a (Nav1.5) expression in the ventricular conduction system (VCS) via a TBX5-responsive enhancer downstream of Scn5a dependent on canonical T-box binding sites. Deletion of Tbx5 from mature VCS causes severe conduction defects, arrhythmias, and sudden death without altering VCS fate. Tbx5 also maintains Cx40 expression in the VCS.\",\n      \"method\": \"Conditional knockout in mature VCS, cardiac electrophysiology, ChIP, enhancer-reporter assay in vivo, T-box binding site mutagenesis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — conditional KO with electrophysiological phenotype, ChIP, and enhancer mutagenesis establishing direct transcriptional target link\",\n      \"pmids\": [\"22728936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tbx5 haploinsufficiency in mouse causes impaired ventricular relaxation and reduced SERCA2a (Atp2a2) expression; Tbx5 directly activates the Atp2a2 promoter. Ca2+ uptake dynamics are impaired in Tbx5+/- cardiomyocytes. HOS patients also have diastolic filling abnormalities, defining a direct Tbx5-Atp2a2 pathway regulating cardiac diastolic function.\",\n      \"method\": \"Tbx5 haploinsufficient mouse model, echocardiography, calcium imaging, luciferase reporter assay with Atp2a2 promoter, human clinical data\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo model with cellular calcium measurements, direct promoter activation assay, and human validation\",\n      \"pmids\": [\"18378906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tbx5 is expressed in a subpopulation of endocardial cells; endocardial-specific deletion of Tbx5 causes fully penetrant atrial septal defects via increased apoptosis of Tbx5-null endocardial cells and neighboring Tbx5-positive myocardial cells through activation of endocardial NOS (Nos3). Compound Tbx5/Nos3 haploinsufficiency worsens cardiac phenotype.\",\n      \"method\": \"Endocardium-specific conditional knockout in mouse, TUNEL apoptosis assay, compound heterozygous crosses, immunohistochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with mechanistic cellular (apoptosis) and genetic (Nos3 interaction) readouts\",\n      \"pmids\": [\"20974940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Shox2 directly activates Bmp4 gene transcription in the pacemaker region; Tbx5 regulates Shox2 expression in the inflow tract and cooperates with Nkx2.5 to regulate Shox2 and Bmp4, establishing a Tbx5-Shox2-Bmp4 molecular pathway in pacemaker development.\",\n      \"method\": \"ChIP, luciferase reporter assays, ectopic expression in Xenopus, siRNA knockdown in cardiomyocytes, Tbx5del/+ and Shox2-/- mouse models\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays for Shox2-Bmp4 direct interaction; mouse genetic models for Tbx5 upstream of Shox2; single lab\",\n      \"pmids\": [\"20858598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A gain-of-function TBX5 p.G125R mutation shows enhanced DNA binding and significantly augmented activation of NPPA, Cx40, Kcnj2, and Tbx3 promoters; maintains normal Nkx2-5 interaction and correct nuclear targeting. This is associated with paroxysmal atrial fibrillation with mild skeletal phenotype, establishing that TBX5 gain-of-function can cause AF.\",\n      \"method\": \"Luciferase reporter assays, EMSA, co-immunoprecipitation, immunofluorescence localization, clinical family analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple biochemical assays with gain-of-function mutation and clinical correlation; later replicated with mouse knockin model\",\n      \"pmids\": [\"18451335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TBX5 crystal structure of the T-box domain was solved in both DNA-unbound and DNA-bound forms. A 3(10)-helix at the C-terminus is an inducible recognition element that forms only upon DNA binding. Six HOS mutations in the T-box show reduced thermal stability and reduced DNA-binding affinity; G80R and W121G show the most severe destabilization.\",\n      \"method\": \"X-ray crystallography, circular dichroism, isothermal titration calorimetry\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of bound and unbound forms combined with thermodynamic measurements of HOS mutants; direct structural mechanism\",\n      \"pmids\": [\"20450920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tbx5 generates alternatively spliced isoforms: a full-length 518-aa protein and a shorter C-terminally truncated isoform. The short isoform retains DNA binding but has altered GATA-4 interaction. The two isoforms are oppositely regulated and present in distinct DNA-binding complexes. The long isoform expression correlates with growth stimulation and promotes cardiac hypertrophy when re-expressed in postnatal transgenic mouse hearts.\",\n      \"method\": \"RT-PCR, co-immunoprecipitation, transgenic mouse overexpression, C2C12 cell overexpression with growth/death assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — alternative splicing demonstrated biochemically with functional consequences in vivo and in vitro; single lab\",\n      \"pmids\": [\"18391012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Tbx5 directly induces expression of the beta2 CaMK-II (camk2b2) isoform; morpholino knockdown of camk2b2 phenocopies tbx5 morphant cardiac and fin defects (bradycardia, elongated heart, diminished pectoral fins). Ectopic cytosolic CaMK-II expression in tbx5 morphants rescues cardiac phenotype, establishing Tbx5-CaMK-II as a functional pathway in cardiac and fin morphogenesis.\",\n      \"method\": \"Zebrafish morpholino knockdown of camk2b2 and tbx5, ectopic CaMK-II rescue in tbx5 morphants, overexpression in mouse fibroblasts (CaMK-II quantification), expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with genetic rescue experiment establishing functional epistasis; single lab\",\n      \"pmids\": [\"19345202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Stat3 directly binds the Tbx5 promoter and activates Tbx5 expression in response to gp130 receptor activation; Tbx5 expression is dependent on Stat3 during P19CL6 cardiomyocyte differentiation, placing Stat3 upstream of Tbx5 in cardiac differentiation.\",\n      \"method\": \"ChIP, luciferase reporter assays, siRNA knockdown of Stat3, P19CL6 differentiation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays with functional KD; single lab\",\n      \"pmids\": [\"20522556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Myocardin physically interacts with TBX5 through the basic domain of myocardin and the coil domain of Tbx5; they synergistically activate cardiac-specific ANF and alpha-MHC (but not smooth muscle) gene expression in a TBE-binding-site-dependent manner. The HOS mutation Tbx5G80R fails to synergize with myocardin.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assays, domain mapping, mutagenesis in cell culture\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus reporter assay with domain mapping and disease-mutation validation; single lab\",\n      \"pmids\": [\"21897873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Foxf1a and Foxf2 are TBX5 target genes in the second heart field: a Foxf1a cis-regulatory element binds TBX5 and GLI1/GLI3 in vivo; GLI1 and TBX5 synergistically activate this element in vitro. This molecular interaction explains the genetic interaction between Tbx5 and Hedgehog signaling for cardiac septation.\",\n      \"method\": \"Whole-genome transcriptional profiling, GLI-ChIP, TBX5 ChIP, luciferase reporter assays, compound haploinsufficiency mouse crosses\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP identifying direct TBX5 binding to enhancer, combined with in vitro transcriptional synergy and in vivo genetic validation\",\n      \"pmids\": [\"25356765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Adult-specific deletion of Tbx5 causes spontaneous atrial fibrillation (AF) with action potential abnormalities rescued by calcium chelation. TBX5 directly activates PITX2, and TBX5 and PITX2 antagonistically regulate membrane effector genes Scn5a, Gja1, Ryr2, Dsp, and Atp2a2. Pitx2 haploinsufficiency rescues the AF and gene expression defects caused by Tbx5 haploinsufficiency, defining an incoherent feed-forward loop.\",\n      \"method\": \"Adult-specific conditional Tbx5 knockout, ECG, action potential recordings, calcium chelation rescue, compound Tbx5/Pitx2 haploinsufficiency, gene expression analysis\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional KO with electrophysiological rescue and compound genetic epistasis defining transcriptional network architecture\",\n      \"pmids\": [\"27582060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TBX5 directly drives Wnt2 and Wnt2b expression in cardiopulmonary mesoderm via ChIP-identified cis-regulatory elements at Wnt2, initiating a mesoderm-to-endoderm Wnt signaling loop required for pulmonary endoderm specification and subsequent atrial septation. Tbx5 cooperates with Shh signaling to drive Wnt2b for lung morphogenesis.\",\n      \"method\": \"Conditional Tbx5 knockout in mice, Tbx5 knockdown in amphibians (Xenopus), TBX5 ChIP-sequencing, in vitro Wnt2 promoter assays, enhancer reporter rescue in zebrafish tbx5 mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — TBX5 ChIP-seq identifying direct targets combined with multi-organism genetic models and enhancer functional validation\",\n      \"pmids\": [\"30352852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TBX5 deficiency causes atrial fibrillation through decreased SERCA2a-mediated SR calcium uptake, balanced by enhanced trans-sarcolemmal calcium fluxes (Ica and NCX), creating triggered activity. Phospholamban removal (which normalizes SERCA function) rescues action potential defects, cardiomyocyte ectopy, and AF, directly linking TBX5 transcriptional control to SERCA2 activity and AF.\",\n      \"method\": \"Adult-specific conditional Tbx5 knockout, patch clamp electrophysiology, calcium imaging, genetic rescue (phospholamban removal), optical mapping\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with genetic rescue experiment and cellular electrophysiology/calcium imaging identifying specific cellular mechanism\",\n      \"pmids\": [\"30896405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TBX5 haploinsufficiency in human iPSC-derived cardiomyocytes causes dysregulation of TBX5-dependent pathways in discrete cardiomyocyte subpopulations. A genetic interaction between Tbx5 and Mef2c causing ventricular septation defects was validated in mice, establishing Mef2c as a TBX5 dosage-sensitive cardiac network node.\",\n      \"method\": \"Human iPSC cardiomyocyte differentiation with TBX5 heterozygous deletion, single-cell RNA-seq, spatial transcriptomics, GRN analysis, compound Tbx5/Mef2c heterozygous mouse validation\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human iPSC model with single-cell resolution combined with in vivo mouse genetic validation of GRN-predicted interaction\",\n      \"pmids\": [\"33321106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tbx5 directly maintains expression of Aldh1a2 (RA-synthesizing enzyme) in the foregut lateral plate mesoderm via an evolutionarily conserved intronic enhancer. Tbx5/Aldh1a2-dependent RA signaling directly activates Shh transcription in the foregut endoderm through a conserved MACS1 enhancer, establishing a Tbx5-RA-Shh-Wnt signaling cascade for cardiopulmonary development.\",\n      \"method\": \"Xenopus and mouse conditional Tbx5 knockout, TBX5 ChIP on Aldh1a2 enhancer, shh enhancer ChIP, luciferase reporter assays, epistasis experiments\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct ChIP on conserved enhancers, cross-species validation, and pathway epistasis establishing mechanistic cascade\",\n      \"pmids\": [\"34643182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TBX5 increases SCN5A transcription and represses CAMK2D and SPTBN4; p.F206L TBX5 fails to transactivate SCN5A (loss-of-function causing Brugada syndrome with reduced INa); p.D111Y TBX5 increases SCN5A but fails to repress CAMK2D/SPTBN4, leading to increased late INa and AP prolongation (Long QT syndrome). Ranolazine rescues the QT prolongation in p.D111Y mice.\",\n      \"method\": \"hiPSC-CM electrophysiology, HL-1 cell assays, transgenic mouse cardiomyocytes, luciferase reporter, ECG, pharmacological rescue\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple experimental systems (hiPSC-CM, HL-1, transgenic mouse), promoter assays, and pharmacological rescue establishing distinct molecular mechanisms for two variants\",\n      \"pmids\": [\"33576403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The TBX5-p.G125R gain-of-function variant in mice causes atrial arrhythmias with prolonged action potentials, decreased systolic/diastolic Ca2+ concentrations, and profound transcriptional deregulation (>1000 differentially expressed transcripts in cardiomyocytes). Epigenetic profiling shows thousands of TBX5-p.G125R-sensitive regulatory elements with increased chromatin accessibility occupied by Tbx5, suggesting altered DNA binding and cooperativity changes the atrial transcriptional regulatory network.\",\n      \"method\": \"Mouse knockin of TBX5-G125R, ECG, optical mapping, patch clamp, calcium measurements, single-nucleus RNA-seq, ATAC-seq, H3K27ac CUT&RUN, HiChIP\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — knockin mouse with comprehensive multi-omic profiling (transcriptomics + epigenomics) and electrophysiological characterization\",\n      \"pmids\": [\"35113653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TBX5 is required in post-natal atrial cardiomyocytes to maintain atrial identity by binding to and preserving the chromatin architecture of atrial-specific enhancers. Atrial-specific Tbx5 KO downregulates atrial cardiomyocyte gene expression; 69% of control-enriched open chromatin regions are TBX5-bound. TBX5 dosage influences 510 chromatin loops including atrial enhancer anchors.\",\n      \"method\": \"Atrial-specific conditional Tbx5 knockout, single-nucleus RNA-seq plus ATAC-seq, H3K27ac HiChIP chromatin looping\",\n      \"journal\": \"Nature cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with concurrent epigenomic and transcriptomic profiling at single-nucleus resolution; TBX5 chromatin binding correlated with regulatory element activity\",\n      \"pmids\": [\"38344303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Tbx5 and Osr1 interact genetically in the posterior SHF to regulate cell cycle progression (specifically G2/M phase entry) for cardiac septation; compound Tbx5/Osr1 haploinsufficiency causes increased AVSDs with reduced Cdk6 expression; disruption of Pten in atrial septum progenitors rescues the AVSDs. Osr1 expression in the pSHF depends on Tbx5 level before E10.5.\",\n      \"method\": \"Conditional compound haploinsufficiency in mouse, cell cycle analysis, Pten genetic rescue, cell fate mapping, immunohistochemistry\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — compound genetic epistasis with genetic rescue; single lab\",\n      \"pmids\": [\"25986147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tbx5 directly regulates Pcsk6 in the posterior SHF as established by ChIP-qPCR and luciferase reporter assay, as part of a gene network module with Osr1 required for atrial septation.\",\n      \"method\": \"RNA-seq in pSHF of multiple mouse genotypes, ChIP-qPCR, luciferase reporter assay, human genetic study\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay for direct Tbx5-Pcsk6 relationship; supported by in vivo expression analysis; single lab\",\n      \"pmids\": [\"26744331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TBX5 is expressed throughout the embryonic epicardium and coronary vasculature. Retrovirus-mediated Tbx5 overexpression inhibits proepicardial cell incorporation into the nascent epicardium; antisense knockdown also prevents proepicardial cell migration. This bidirectional sensitivity indicates Tbx5 regulates proepicardial cell migration, and proepicardial cells downregulate Tbx5 during normal migration.\",\n      \"method\": \"Immunohistochemistry of human embryonic tissue, retroviral overexpression and antisense knockdown in chick PEO, PEO explant culture\",\n      \"journal\": \"Physiological genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both gain- and loss-of-function experiments in chick with specific cellular migration phenotype; single lab\",\n      \"pmids\": [\"15138308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Proepicardial-specific deletion of Tbx5 in mouse impairs epicardial attachment, delays epicardial-derived cell migration, reduces vascular smooth muscle cell recruitment, and causes defective coronary vasculogenesis with myocardial hypoxia and reduced exercise capacity.\",\n      \"method\": \"Conditional Tbx5 knockout (proepicardial-specific Cre), histology, immunostaining for epicardial-derived cells, HIF-1alpha expression, exercise testing\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined cellular and functional phenotypes (coronary vasculogenesis defect, exercise capacity); confirmed in both chick and mouse\",\n      \"pmids\": [\"25245104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss of Tbx5 in mouse lung mesenchyme leads to unilateral absence of lung bud specification and absence of tracheal specification in organ culture. Double Tbx4/Tbx5 conditional mutants show severe lung branching arrest with downregulation of Wnt2, Fgf10, Bmp4, and Spry2. Tbx4 and Tbx5 interact genetically with Fgf10 during lung growth and branching but not tracheal cartilage development.\",\n      \"method\": \"Conditional Tbx4/Tbx5 knockout using two different Cre lines, ex vivo organ culture, in situ hybridization, genetic interaction analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with multiple Cre lines, genetic interaction, and organ culture rescue experiments\",\n      \"pmids\": [\"22876201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A TBX5 enhancer ~90 kb downstream of TBX5 drives heart-restricted expression; a homozygous single-base-pair mutation in this enhancer found in an isolated CHD patient abrogates its ability to drive cardiac expression in both mouse and zebrafish transgenic models, demonstrating that non-coding regulatory mutations in TBX5 enhancers can cause isolated congenital heart disease without limb defects.\",\n      \"method\": \"Genomic/bioinformatic enhancer scanning, transgenic mouse and zebrafish enhancer reporter assays, enhancer mutation functional testing in vivo\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo enhancer reporter assay in two model organisms with disease mutation functional validation; single patient but two orthogonal transgenic models\",\n      \"pmids\": [\"22543974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Pax6 physically interacts with Tbx5 and cVax; Pax6 overexpression in chick optic cup expands Tbx5 and Bmp4 domains while reducing cVax. cVax and Tbx5 oppositely modulate Pax6 alpha-enhancer activity; Pax6/cVax interaction inhibits Pax6 transactivation. Together, Pax6, cVax, and Tbx5 mediate dorsoventral patterning of the eye.\",\n      \"method\": \"In ovo electroporation in chick, co-immunoprecipitation, luciferase reporter assays, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and reporter assays combined with in vivo electroporation; single lab\",\n      \"pmids\": [\"15322073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TBX5 is autoregulated; ectopically expressed TBX5 increases activity of its own promoter through TBE-B, TBE-C, and NKX2.5 binding sites in the 5'-flanking region. A GC box and T-box-like elements are functionally required for TBX5 promoter activity, as shown by site-directed mutagenesis, DNase footprinting, and EMSA.\",\n      \"method\": \"Site-directed mutagenesis, DNase I footprinting, EMSA, luciferase reporter assays, transient transfection\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple biochemical methods (EMSA, footprinting, reporter) establishing autoregulation; single lab\",\n      \"pmids\": [\"15095414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Ventricular-specific Tbx5 deletion in adult mice causes mild cardiac dysfunction, arrhythmias, and high mortality (60%) from sudden cardiac death. RNA-seq and ChIP identify 47 TBX5-controlled transcripts including Gja1, Kcnj5, Kcng2, Cacna1g, Chrm2 (conduction/contraction), Fhl2 (cardioprotection), and cytoskeletal genes. AAV9-mediated TBX5 protein normalization after arrhythmia development re-establishes TBX5-dependent transcriptome, reduces arrhythmia propensity, and ameliorates cardiac dysfunction.\",\n      \"method\": \"Conditional ventricular Tbx5 KO, RNA-seq, TBX5 ChIP, AAV9 rescue experiment, ECG monitoring\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with ChIP-validated direct targets plus therapeutic rescue experiment demonstrating reversibility\",\n      \"pmids\": [\"32777030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-10a and miR-10b directly target the 3'-UTR of TBX5 to repress TBX5 protein expression, establishing post-transcriptional regulation of TBX5 dosage.\",\n      \"method\": \"Luciferase 3'-UTR reporter assay, RT-qPCR, Western blot after miRNA mimic/inhibitor transfection\",\n      \"journal\": \"Pediatric cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3'-UTR reporter assay combined with protein-level validation; single lab\",\n      \"pmids\": [\"24714979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hox genes directly regulate Tbx5 forelimb-specific expression; the minimal regulatory element sufficient for forelimb-restricted Tbx5 expression is Hox-responsive. Hoxc9 (expressed in caudal LPM) forms a repressive complex on the Tbx5 forelimb regulatory element through two protein domains, while Hox proteins in rostral LPM form activating complexes, achieving positional restriction of Tbx5.\",\n      \"method\": \"Transgenic mouse enhancer-reporter assays, electroporation, ChIP, mutagenesis of Hox binding sites, in vitro transcriptional assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — regulatory element identified by transgenic reporter, Hox responsiveness confirmed by multiple approaches including ChIP and mutagenesis\",\n      \"pmids\": [\"22872086\", \"24651482\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TBX5 is a T-box transcription factor that binds DNA through its T-box domain (crystallographically characterized) and functions as a dosage-sensitive transcriptional activator in heart and limb development by physically interacting with partner transcription factors NKX2-5, GATA4, MEF2C, TBX20, and myocardin to synergistically activate cardiac target genes (including NPPA/ANF, SCN5A/Nav1.5, Cx40, Atp2a2/SERCA2a, Aldh1a2, Wnt2/2b); its nuclear localization is regulated by the LMP4/PDLIM7 cytoskeletal anchor and a defined NLS (KRK at aa325-327); it is required in the second heart field for atrial septation (via a Hedgehog-Foxf-Wnt pathway), in the ventricular conduction system for fast conduction, in the mature atrium for atrial identity maintenance through TBX5-dependent enhancer chromatin architecture, and in the proepicardium for coronary vasculogenesis, while its haploinsufficiency causes HOS and its adult loss or gain-of-function both cause atrial fibrillation through distinct effects on calcium handling (SERCA2a/SR Ca2+ sequestration) and atrial electrophysiology.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TBX5 is a dosage-sensitive T-box transcription factor that orchestrates heart and limb development by binding T-box (Brachyury-type) DNA consensus sites through its T-box domain and activating chamber- and tissue-specific gene programs [#0, #5, #31]. Crystallographic analysis of the T-box domain in DNA-bound and unbound states defines an inducible C-terminal 3(10)-helix recognition element, and HOS-associated T-box mutations reduce thermal stability and DNA-binding affinity [#31]; the protein carries a discrete transactivation domain (aa 339–379) and a KRK nuclear localization signal at aa 325–327 [#16]. TBX5 functions combinatorially, physically partnering with NKX2-5, GATA4, MEF2C, TBX20, and myocardin to synergistically activate cardiac targets such as NPPA, MYH6, and SCN5A, and disease mutations selectively dissociate DNA binding from these protein–protein synergies [#1, #2, #15, #21, #35]. In the second heart field it drives atrial septation through a Hedgehog–Foxf–RA–Wnt regulatory cascade and Osr1-dependent progenitor cell-cycle control [#25, #36, #41, #45], and in conducting and working myocardium it directly activates Scn5a/Nav1.5, Cx40, and SERCA2a/Atp2a2 to govern fast conduction and calcium handling [#17, #26, #27]. In the mature atrium TBX5 maintains atrial identity by binding and preserving the chromatin architecture of atrial-specific enhancers and loops [#44], and operates in an incoherent feed-forward loop with PITX2 to set membrane-effector gene dosage [#37]. TBX5 nuclear availability is restrained by the PDLIM7/LMP4 cytoskeletal anchor [#22], and its transcript dosage is tuned by autoregulation and miR-10-mediated repression [#52, #54]. Heterozygous loss-of-function mutations cause Holt-Oram syndrome, while distinct adult loss- and gain-of-function alleles drive atrial fibrillation and arrhythmia syndromes through opposing effects on SERCA2a-dependent SR calcium uptake and atrial electrophysiology [#0, #30, #37, #39, #43].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established TBX5 as a disease gene, linking a single T-box transcription factor to coordinated heart and limb development through haploinsufficiency.\",\n      \"evidence\": \"Positional cloning and mutation identification in Holt-Oram syndrome pedigrees\",\n      \"pmids\": [\"8988165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define molecular targets or partners\", \"Did not explain dosage sensitivity mechanism\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed TBX5 expression is graded and chamber-restricted, providing a spatial basis for the left-sided and septal cardiac defects of HOS.\",\n      \"evidence\": \"In situ hybridization in mouse and chick hearts correlated with human phenotype\",\n      \"pmids\": [\"10373308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Correlative, not functional\", \"Mechanism establishing the gradient not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated TBX5 directly specifies chamber-specific gene programs and global cardiac identity, beyond a role in septation alone.\",\n      \"evidence\": \"Dominant-negative Tbx5 in Xenopus and beta-MHC-driven ectopic ventricular expression in transgenic mice\",\n      \"pmids\": [\"10079235\", \"10864469\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct target genes not yet identified\", \"Single-organism dominant-negative caveats\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the DNA-binding determinants and the first transcription-factor partner, explaining why distinct HOS mutations cause organ-selective phenotypes.\",\n      \"evidence\": \"Binding-site selection, EMSA, reporter assays, yeast two-hybrid and co-IP with NKX2-5; structural mapping to the Xbra T-box\",\n      \"pmids\": [\"11555635\", \"11431700\", \"10077612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether DNA-binding and partner-interaction defects are separable\", \"Structural inference based on Xbra not TBX5\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Systematic mutational analysis separated two failure modes — loss of DNA binding versus loss of NKX2-5 synergy — and showed mutants mislocalize partly to cytoplasm.\",\n      \"evidence\": \"EMSA, co-IP, reporter assays, and immunofluorescence localization across seven HOS missense mutations\",\n      \"pmids\": [\"12499378\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mislocalization mechanism not yet linked to an NLS or anchor\", \"Did not test all partner complexes\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined TBX5 as essential for limb initiation and outgrowth, operating in a WNT→Tbx5→Fgf10 feedback circuit acting on mesodermal cell migration.\",\n      \"evidence\": \"Zebrafish heartstrings mutant, morpholino knockdown, and gain/loss-of-function epistasis in chick and zebrafish\",\n      \"pmids\": [\"12223419\", \"12066188\", \"12399308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct limb transcriptional targets not fully mapped\", \"Cross-species relevance to mammalian forelimb assumed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Confirmed mammalian requirement for forelimb initiation and identified GATA4 as a second cooperative cardiac partner whose disease mutation disrupts the TBX5 interaction.\",\n      \"evidence\": \"Conditional mouse forelimb KO with chick misexpression; reciprocal co-IP/pull-down and reporter assays for GATA4\",\n      \"pmids\": [\"12736217\", \"12845333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define genome-wide GATA4-TBX5 cobound targets\", \"Quantitative dosage contribution of each partner unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped functional protein domains (transactivation aa339-379, KRK NLS aa325-327) and identified PDLIM7/LMP4 as a cytoskeletal anchor restraining nuclear TBX5 activity, plus MEF2C as a further partner.\",\n      \"evidence\": \"Deletion/point mutagenesis, GAL4 fusions, Y2H, co-IP, FRET, live-cell imaging, and reporter assays\",\n      \"pmids\": [\"15087119\", \"15302601\", \"16880269\", \"19204083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals controlling LMP4-mediated shuttling not defined\", \"Whether anchoring is regulated developmentally unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established a TBX5-NKX2-5-Id2 pathway required for ventricular conduction system specification, linking combinatorial transcription to a defined lineage.\",\n      \"evidence\": \"SAGE profiling, Id2-null mice, reporter assays, compound haploinsufficiency, and electrophysiology\",\n      \"pmids\": [\"17604724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct genomic Id2 enhancer occupancy in vivo not shown\", \"Downstream conduction effectors not enumerated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Revealed that TBX5 gain-of-function (p.G125R) with enhanced DNA binding and target activation causes atrial fibrillation, establishing bidirectional dosage sensitivity, and that alternative splicing modulates GATA4 interaction.\",\n      \"evidence\": \"Reporter assays, EMSA, co-IP, localization, and clinical family analysis; RT-PCR and transgenic isoform studies\",\n      \"pmids\": [\"18451335\", \"18391012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo electrophysiological mechanism of G125R not yet defined (resolved later)\", \"Isoform functional consequences only partially characterized\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Solved the T-box domain crystal structures and connected direct transcriptional targets (Atp2a2/SERCA2a, Shox2-Bmp4) to TBX5 control of calcium handling and pacemaker development.\",\n      \"evidence\": \"X-ray crystallography, CD, ITC; Tbx5 haploinsufficient mice with promoter assays, calcium imaging, and ChIP\",\n      \"pmids\": [\"20450920\", \"18378906\", \"20858598\", \"20522556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure lacked partner-bound complexes\", \"Did not show how single targets integrate into network-level dosage effects\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined direct, enhancer-level control of conduction (Scn5a/Cx40) and progenitor-pathway architecture for atrial septation (Hedgehog parallel role), and a requirement in lung specification.\",\n      \"evidence\": \"Mature-VCS and second-heart-field conditional KOs, ChIP, enhancer reporter mutagenesis, Hh rescue; conditional Tbx4/Tbx5 lung KO and enhancer-mutation CHD modeling\",\n      \"pmids\": [\"22728936\", \"22898775\", \"22876201\", \"22543974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of progenitor cell-cycle effectors incomplete\", \"Tissue-specific cofactors at conduction enhancers not enumerated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected TBX5 directly to Hedgehog output (Foxf1a via GLI cooperativity) and to proepicardial/coronary vasculogenesis, integrating septation signaling with vascular development.\",\n      \"evidence\": \"TBX5 and GLI ChIP, reporter synergy, compound haploinsufficiency; proepicardial-specific KO with vascular and exercise phenotypes\",\n      \"pmids\": [\"25356765\", \"25245104\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative GLI-TBX5 cooperativity at single enhancers not resolved\", \"Coronary defect's transcriptional targets in epicardium not mapped\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined the incoherent feed-forward loop between TBX5 and its direct target PITX2 that sets atrial membrane-effector dosage, establishing the transcriptional logic underlying atrial fibrillation.\",\n      \"evidence\": \"Adult conditional Tbx5 KO, ECG, action potential and calcium-chelation rescue, compound Tbx5/Pitx2 epistasis; pSHF ChIP for Pcsk6\",\n      \"pmids\": [\"27582060\", \"26744331\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise stoichiometry of TBX5/PITX2 antagonism at each target unclear\", \"Did not isolate the dominant arrhythmogenic effector\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed TBX5 at the apex of a mesoderm-to-endoderm Wnt2/Wnt2b-RA-Shh signaling cascade required for pulmonary specification and downstream atrial septation.\",\n      \"evidence\": \"TBX5 ChIP-seq, conditional mouse KO, Xenopus knockdown, enhancer-reporter rescue in zebrafish; RA/Shh enhancer ChIP and epistasis\",\n      \"pmids\": [\"30352852\", \"34643182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Feedback between Wnt/RA/Shh loops not fully ordered\", \"Cell-population specificity of each enhancer not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified the specific cellular mechanism of TBX5-deficient atrial fibrillation: reduced SERCA2a-mediated SR calcium uptake balanced by trans-sarcolemmal flux, generating triggered activity, rescuable by restoring SERCA function.\",\n      \"evidence\": \"Adult conditional KO with patch clamp, calcium imaging, optical mapping, and phospholamban-removal genetic rescue\",\n      \"pmids\": [\"30896405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which transcriptional targets dominate the SR/sarcolemmal imbalance\", \"Translational reversibility window not defined here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved TBX5 dosage effects to discrete cardiomyocyte subpopulations and validated MEF2C as a dosage-sensitive network node for ventricular septation using human and mouse genetics.\",\n      \"evidence\": \"TBX5-heterozygous human iPSC-CMs with single-cell RNA-seq and spatial transcriptomics, GRN analysis, and compound Tbx5/Mef2c mouse validation\",\n      \"pmids\": [\"33321106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subpopulation-specific direct targets not exhaustively mapped\", \"Human-mouse network conservation only partially tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated reversibility of TBX5-dependent disease: restoring TBX5 protein after arrhythmia onset re-establishes its direct transcriptome and ameliorates dysfunction, defining ongoing transcriptional maintenance roles.\",\n      \"evidence\": \"Ventricular conditional KO, RNA-seq, ChIP-validated targets, and AAV9-mediated TBX5 rescue with ECG monitoring\",\n      \"pmids\": [\"32777030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Durability and dosage precision of AAV rescue not fully characterized\", \"Mechanism of transcriptome re-establishment at chromatin level not shown here\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed TBX5 maintains adult atrial identity and arrhythmia susceptibility through enhancer chromatin architecture, and that distinct missense variants produce mechanistically separable channelopathies (Brugada, Long QT) via differential SCN5A/CAMK2D control.\",\n      \"evidence\": \"Atrial- and variant-knockin mouse models, snRNA/ATAC-seq, H3K27ac HiChIP/CUT&RUN, hiPSC-CM and HL-1 electrophysiology, and pharmacological (ranolazine) rescue\",\n      \"pmids\": [\"38344303\", \"35113653\", \"33576403\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TBX5 dosage sets specific loop anchors mechanistically unresolved\", \"Generalizability of variant-specific channel mechanisms to other alleles unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TBX5 mechanistically reads dosage to selectively reconfigure enhancer cooperativity and chromatin looping in a partner- and tissue-specific manner remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of TBX5 bound with partner transcription factors on composite enhancers\", \"Mechanism converting small dosage changes into discrete chromatin-architecture shifts not defined\", \"Signals controlling TBX5 nuclear availability in vivo not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 31, 26]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 14, 16, 44]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 16]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [15, 22]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [44]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 14, 26, 44]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 8, 25, 38, 41]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [43, 44]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [27, 39, 53]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 30, 37, 42]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NKX2-5\", \"GATA4\", \"MEF2C\", \"TBX20\", \"MYOCD\", \"PDLIM7\", \"PITX2\", \"PAX6\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}